Mary M. Horowitz MD, MS
Research Areas of Interest
AdultAllograftsBone Marrow TransplantationClinical Trials as TopicData CollectionDatabases, FactualDonor SelectionHematopoietic Stem Cell TransplantationHumansMulticenter Studies as TopicNeoplasms, Second PrimaryResearch DesignRisk FactorsTissue DonorsTransplantation, AutologousLeadership Positions
Scientific Director Emeritus, Center for International Blood and Marrow Transplant ResearchDeputy Cancer Center DirectorDirector, Data and Coordinating Center, Blood and Marrow Transplant Clinical Trials NetworkMCW Program / Core Facilities
Center for International Blood and Marrow Transplant ResearchPublications (509)
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. (Pasquini MC, Wallace PK, Logan B, Kaur M, Tario JD, Howard A, Zhang Y, Brunstein C, Efebera Y, Geller N, Giralt S, Hari P, Horowitz MM, Koreth J, Krishnan A, Landau H, Somlo G, Shah N, Stadtmauer E, Vogl DT, Vesole DH, McCarthy PL, Hahn T) J Clin Oncol 2024 May 03:JCO2300934 PMID: 38701390 05/03/2024 Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3. (Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB, BMT-CTN 1506/MORPHO Study Investigators) J Clin Oncol 2024 Mar 12:JCO2302474 PMID: 38471061 03/12/2024 Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study (McCarthy PL, Attwood KM, Liu X, Chen GL, Minderman H, Alousi A, Bashey A, Lowsky R, Miklos DB, Hansen J, Westervelt P, Yanik G, Waller EK, Howard A, Blazar BR, Wallace PK, Reshef R, Horowitz MM, Maziarz RT, Levine JE, Mohammadpour H) Bone Marrow Transplantation March 2024;59(3):334-343 SCOPUS ID: 2-s2.0-85180197872 03/01/2024 SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101). (Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Howard DS, Ibrahim U, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA) medRxiv 2024 Jan 25 PMID: 38343800 PMCID: PMC10854344 02/12/2024 Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. (Eapen M, Kou J, Andreansky M, Bhatia M, Brochstein J, Chaudhury S, Haight AE, Haines H, Jacobsohn D, Jaroscak J, Kasow KA, Krishnamurti L, Levine JE, Leung K, Margolis D, Yu LC, Horowitz MM, Kamani N, Walters MC, Shenoy S) Am J Hematol 2024 Apr;99(4):785-788 PMID: 38343182 PMCID: PMC10947844 SCOPUS ID: 2-s2.0-85185139592 02/12/2024 Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients. (Shaw BE, Flynn KE, He N, Cusatis R, D'Souza A, Hamilton BK, Horowitz MM, Mattila D, Phelan R, Lee SJ, Brazauskas R) Cancer 2024 May 15;130(10):1826-1835 PMID: 38198511 PMCID: PMC11058023 SCOPUS ID: 2-s2.0-85181878144 01/10/2024 Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. (McCarthy PL, Attwood KM, Liu X, Chen GL, Minderman H, Alousi A, Bashey A, Lowsky R, Miklos DB, Hansen J, Westervelt P, Yanik G, Waller EK, Howard A, Blazar BR, Wallace PK, Reshef R, Horowitz MM, Maziarz RT, Levine JE, Mohammadpour H) Bone Marrow Transplant 2024 Mar;59(3):334-343 PMID: 38110620 PMCID: PMC10961739 SCOPUS ID: 2-s2.0-85180197872 12/19/2023 Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML. (Fein JA, Shouval R, Krieger E, Spellman SR, Wang T, Baldauf H, Fleischhauer K, Kröger N, Horowitz M, Maiers M, Miller JS, Mohty M, Nagler A, Weisdorf D, Malmberg KJ, Toor AA, Schetelig J, Romee R, Koreth J) Blood Adv 2024 Feb 13;8(3):581-590 PMID: 38052043 PMCID: PMC10837477 SCOPUS ID: 2-s2.0-85185534011 12/06/2023 1 CitationAllogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. (Versluis J, Saber W, Tsai HK, Gibson CJ, Dillon LW, Mishra A, McGuirk J, Maziarz RT, Westervelt P, Hegde P, Mukherjee D, Martens MJ, Logan B, Horowitz M, Hourigan CS, Nakamura R, Cutler C, Lindsley RC, Blood and Marrow Transplant Clinical Trials Network) J Clin Oncol 2023 Oct 01;41(28):4497-4510 PMID: 37607457 PMCID: PMC10552956 SCOPUS ID: 2-s2.0-85175320632 08/23/2023 8 CitationsApplication of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis. (Cho C, Devlin S, Maloy M, Horowitz MM, Logan B, Rizzo JD, Giralt SA, Perales MA) Bone Marrow Transplant 2023 Oct;58(10):1089-1095 PMID: 37422574 PMCID: PMC10592419 SCOPUS ID: 2-s2.0-85164194423 07/09/2023 How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy? (Juckett M, Dandoy C, DeFilipp Z, Kindwall-Keller TL, Spellman SR, Ustun C, Waldman BM, Weisdorf DJ, Wood WA, Horowitz MM, Burns LJ, Khera N) Blood Reviews July 2023;60 SCOPUS ID: 2-s2.0-85152945299 07/01/2023 Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. (Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG, BMT CTN 1703 Investigators) N Engl J Med 2023 Jun 22;388(25):2338-2348 PMID: 37342922 PMCID: PMC10575613 SCOPUS ID: 2-s2.0-85164529275 06/21/2023 22 CitationsSARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study. (Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA) EClinicalMedicine 2023 May;59:101983 PMID: 37128256 PMCID: PMC10133891 SCOPUS ID: 2-s2.0-85153604229 05/02/2023 10 CitationsHealth-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101. (El Jurdi N, Martens MJ, Brunstein CG, O'Donnell P, Lee SJ, D'Souza A, Logan B, Hong S, Singh AK, Sandhu K, Shapiro RM, Horowitz MM, Hamilton BK) Transplant Cell Ther 2023 Jul;29(7):467.e1-467.e5 PMID: 37088401 PMCID: PMC10330136 SCOPUS ID: 2-s2.0-85162230932 04/24/2023 1 CitationHow do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy? (Juckett M, Dandoy C, DeFilipp Z, Kindwall-Keller TL, Spellman SR, Ustun C, Waldman BM, Weisdorf DJ, Wood WA, Horowitz MM, Burns LJ, Khera N) Blood Rev 2023 Jul;60:101079 PMID: 37087394 PMCID: PMC10330269 SCOPUS ID: 2-s2.0-85152945299 04/23/2023 Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. (Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacobs BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM) J Clin Oncol 2023 Apr 20;41(12):2227-2237 PMID: 36623245 PMCID: PMC10448940 SCOPUS ID: 2-s2.0-85152619905 01/10/2023 9 CitationsThree-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial. (Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J) Transplant Cell Ther 2023 Mar;29(3):208.e1-208.e6 PMID: 36584941 PMCID: PMC9992261 SCOPUS ID: 2-s2.0-85146784394 12/31/2022 8 CitationsBringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force. (Vasu S, Holtan SG, Shimamura A, Burnworth T, Whisenton S, Adams S, Nuechterlein B, Mortier N, Foster J, DiFronzo N, Horowitz M, Rizzo D, Foley A) Transplant Cell Ther 2023 Jan;29(1):5-9 PMID: 36283516 PMCID: PMC10008748 SCOPUS ID: 2-s2.0-85143267628 10/26/2022 5 CitationsHealth-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102. (Cusatis R, Martens MJ, Nakamura R, Cutler CS, Saber W, Lee SJ, Logan BR, Shaw BE, Gregory A, D'Souza A, Hamilton BK, Horowitz MM, Flynn KE) Am J Hematol 2023 Feb;98(2):229-250 PMID: 36251401 PMCID: PMC9839494 SCOPUS ID: 2-s2.0-85142150726 10/18/2022 5 CitationsCorrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplant Cell Ther 2022 Oct;28(10):717 PMID: 36202527 SCOPUS ID: 2-s2.0-85101258094 10/07/2022 Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplant Cell Ther 2022 Oct;28(10):715-716 PMID: 36202526 SCOPUS ID: 2-s2.0-85108559179 10/07/2022 1 CitationCorrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885, (S1083879120304146), (10.1016/j.bbmt.2020.07.005)] (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplantation and Cellular Therapy October 2022;28(10):717 SCOPUS ID: 2-s2.0-85101258094 10/01/2022 Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)] (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplantation and Cellular Therapy October 2022;28(10):715-716 SCOPUS ID: 2-s2.0-85108559179 10/01/2022 1 CitationHaploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. (DeZern AE, Eapen M, Wu J, Talano JA, Solh M, Dávila Saldaña BJ, Karanes C, Horwitz ME, Mallhi K, Arai S, Farhadfar N, Hexner E, Westervelt P, Antin JH, Deeg HJ, Leifer E, Brodsky RA, Logan BR, Horowitz MM, Jones RJ, Pulsipher MA) Lancet Haematol 2022 Sep;9(9):e660-e669 PMID: 35907408 PMCID: PMC9444987 SCOPUS ID: 2-s2.0-85135889621 07/31/2022 22 CitationsHLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age. (Ambinder A, Jain T, Tsai HL, Horowitz MM, Jones RJ, Varadhan R) Blood Adv 2022 Jul 26;6(14):4335-4346 PMID: 35613462 PMCID: PMC9327541 SCOPUS ID: 2-s2.0-85135175734 05/26/2022 10 CitationsTrajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma. (D'Souza A, Brazauskas R, Stadtmauer EA, Pasquini MC, Hari P, Bashey A, Callander N, Devine S, Efebera Y, Ganguly S, Gasparetto C, Geller N, Horowitz MM, Koreth J, Landau H, Brunstein C, McCarthy P, Qazilbash MH, Giralt S, Krishnan A, Flynn KE) Am J Hematol 2023 Jan;98(1):140-147 PMID: 35567778 PMCID: PMC9659666 SCOPUS ID: 2-s2.0-85130262056 05/15/2022 11 CitationsAre We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice. (Hamilton BK, Cutler C, Divine C, Juckett M, LeMaistre C, Stewart S, Wilder J, Horowitz M, Khera N, Burns LJ) Transplant Cell Ther 2022 Aug;28(8):419-425 PMID: 35550441 PMCID: PMC9364468 SCOPUS ID: 2-s2.0-85132872281 05/14/2022 2 CitationsReaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. (Thanarajasingam G, Minasian LM, Bhatnagar V, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gormley N, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Kwong YL, Little RF, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Nair A, Nastoupil L, Robertson K, Sidana S, Smedby KE, Sonneveld P, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Seymour JF, Habermann TM) Lancet Haematol 2022 May;9(5):e374-e384 PMID: 35483398 PMCID: PMC9241484 SCOPUS ID: 2-s2.0-85129780083 04/29/2022 10 CitationsUpdated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. (Phelan R, Chen M, Bupp C, Bolon YT, Broglie L, Brunner-Grady J, Burns LJ, Chhabra S, Christianson D, Cusatis R, Devine SM, D'Souza A, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini M, Pérez WS, Riches M, Rizzo D, Saber W, Spellman SR, Stefanski HE, Steinert P, Weisdorf D, Horowitz M, Auletta JJ, Shaw BE, Arora M) Transplant Cell Ther 2022 Jul;28(7):409.e1-409.e10 PMID: 35447374 PMCID: PMC9840526 SCOPUS ID: 2-s2.0-85130441260 04/22/2022 25 CitationsRace and Survival in Unrelated Hematopoietic Cell Transplantation. (Morishima Y, Morishima S, Stevenson P, Kodera Y, Horowitz M, McKallor C, Malkki M, Spellman SR, Gooley T, Petersdorf EW, on-behalf-of-the-International Histocompatibility-Working-Group-in-Hematopoietic-Cell-Transplantation) Transplant Cell Ther 2022 Jul;28(7):357.e1-357.e6 PMID: 35405366 PMCID: PMC9387555 SCOPUS ID: 2-s2.0-85130327773 04/12/2022 9 CitationsImpact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012. (Brunstein CG, O'Donnell PV, Logan B, Dawson P, Costa L, Cutler C, Craig M, Hogan W, Horowitz MM, Horwitz ME, Karanes C, Magenau JM, Malone A, McCarty J, McGuirk JP, Morris LE, Rezvani AR, Salit R, Vasu S, Eapen M, Fuchs EJ, Blood and Marrow Transplant Clinical Trials Network) Transplant Cell Ther 2022 Jul;28(7):406.e1-406.e6 PMID: 35390529 PMCID: PMC9253061 SCOPUS ID: 2-s2.0-85130454080 04/08/2022 2 CitationsHLA-DQ heterodimers in hematopoietic cell transplantation. (Petersdorf EW, Bengtsson M, Horowitz M, McKallor C, Spellman SR, Spierings E, Gooley TA, Stevenson P, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Blood 2022 May 19;139(20):3009-3017 PMID: 35271697 PMCID: PMC9121842 SCOPUS ID: 2-s2.0-85130706095 03/11/2022 14 CitationsNeed for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials. (Stewart MD, McCall B, Pasquini M, Yang AS, Britten CD, Chuk M, De Claro RA, George B, Gormley N, Horowitz MM, Kowack E, McCoy C, Morrow PK, Okoye E, Ricafort R, Rossi J, Sharon E, Theoret M, Vegni F, Yu T, Allen J) Cytotherapy 2022 Jul;24(7):742-749 PMID: 35219582 PMCID: PMC9721456 SCOPUS ID: 2-s2.0-85125476704 02/28/2022 2 CitationsDecrease post-transplant relapse using donor-derived expanded NK-cells (Ciurea SO, Kongtim P, Soebbing D, Trikha P, Behbehani G, Rondon G, Olson A, Bashir Q, Gulbis AM, Indreshpal K, Rezvani K, Shpall EJ, Bassett R, Cao K, Martin AS, Devine S, Horowitz M, Pasquini M, Lee DA, Champlin RE) Leukemia January 2022;36(1):155-164 SCOPUS ID: 2-s2.0-85111619774 01/01/2022 46 CitationsRandomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. (Luznik L, Pasquini MC, Logan B, Soiffer RJ, Wu J, Devine SM, Geller N, Giralt S, Heslop HE, Horowitz MM, Jones RJ, Litzow MR, Mendizabal A, Muffly L, Nemecek ER, O'Donnell L, O'Reilly RJ, Palencia R, Schetelig J, Shune L, Solomon SR, Vasu S, Ho VT, Perales MA) J Clin Oncol 2022 Feb 01;40(4):356-368 PMID: 34855460 PMCID: PMC8797487 SCOPUS ID: 2-s2.0-85123901255 12/03/2021 69 CitationsUmbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes. (O'Donnell PV, Brunstein CG, Fuchs EJ, Zhang MJ, Allbee-Johnson M, Antin JH, Leifer ES, Elmariah H, Grunwald MR, Hashmi H, Horowitz MM, Magenau JM, Majhail N, Milano F, Morris LE, Rezvani AR, McGuirk JP, Jones RJ, Eapen M) Transplant Cell Ther 2022 Feb;28(2):109.e1-109.e8 PMID: 34775146 PMCID: PMC8882346 SCOPUS ID: 2-s2.0-85121144074 11/15/2021 12 CitationsAdding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. (Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau LW, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B) Transplant Cell Ther 2022 Feb;28(2):112.e1-112.e9 PMID: 34757219 PMCID: PMC8915447 SCOPUS ID: 2-s2.0-85121127060 11/11/2021 4 CitationsImpact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials? (Wingard JR, Alexander BD, Baden LR, Chen M, Sugrue MW, Leather HL, Caliendo AM, Clancy CJ, Denning DW, Marty FM, Nguyen MH, Wheat LJ, Logan BR, Horowitz MM, Marr KA) Open Forum Infect Dis 2021 Oct;8(10):ofab441 PMID: 34631917 PMCID: PMC8496761 SCOPUS ID: 2-s2.0-85118939894 10/12/2021 3 CitationsBlood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. (Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM) Transplant Cell Ther 2021 Nov;27(11):885-907 PMID: 34461278 PMCID: PMC8556300 SCOPUS ID: 2-s2.0-85116810681 08/31/2021 11 CitationsOne and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. (Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, Frutos C, Galeano S, Hamad N, Hamidieh AA, Hashmi S, Ho A, Horowitz MM, Iida M, Jaimovich G, Karduss A, Kodera Y, Kröger N, Péffault de Latour R, Lee JW, Martínez-Rolón J, Pasquini MC, Passweg J, Paulson K, Seber A, Snowden JA, Srivastava A, Szer J, Weisdorf D, Worel N, Koh MBC, Aljurf M, Greinix H, Atsuta Y, Saber W) Haematologica 2022 May 01;107(5):1045-1053 PMID: 34382386 PMCID: PMC9052915 SCOPUS ID: 2-s2.0-85129777388 08/13/2021 80 CitationsBlood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation. (Warlick ED, Ustun C, Andreescu A, Bonagura AF, Brunner A, Chandra AB, Foran JM, Juckett MB, Kindwall-Keller TL, Klimek VM, Pease DF, Steensma DP, Waldman BM, Horowitz MM, Burns LJ, Khera N) Cancer 2021 Dec 01;127(23):4339-4347 PMID: 34375439 PMCID: PMC8578257 SCOPUS ID: 2-s2.0-85112029966 08/11/2021 4 CitationsDecrease post-transplant relapse using donor-derived expanded NK-cells. (Ciurea SO, Kongtim P, Soebbing D, Trikha P, Behbehani G, Rondon G, Olson A, Bashir Q, Gulbis AM, Indreshpal K, Rezvani K, Shpall EJ, Bassett R, Cao K, Martin AS, Devine S, Horowitz M, Pasquini M, Lee DA, Champlin RE) Leukemia 2022 Jan;36(1):155-164 PMID: 34312462 PMCID: PMC8727305 SCOPUS ID: 2-s2.0-85111619774 07/28/2021 46 CitationsA Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies. (Saber W, Steinert P, Zhang MJ, Chen M, Pope A, Keating A, Wingard JR, Ballen K, Stiff P, Perales MA, Forman S, Champlin R, Langston A, Rudebeck M, Horowitz M) Transplant Cell Ther 2021 Oct;27(10):837.e1-837.e10 PMID: 34224914 PMCID: PMC8606163 SCOPUS ID: 2-s2.0-85111495021 07/06/2021 Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome. (Nakamura R, Saber W, Martens MJ, Ramirez A, Scott B, Oran B, Leifer E, Tamari R, Mishra A, Maziarz RT, McGuirk J, Westervelt P, Vasu S, Patnaik M, Kamble R, Forman SJ, Sekeres MA, Appelbaum F, Mendizabal A, Logan B, Horowitz M, Cutler C) J Clin Oncol 2021 Oct 20;39(30):3328-3339 PMID: 34106753 PMCID: PMC8791814 SCOPUS ID: 2-s2.0-85112086284 06/10/2021 70 CitationsNational Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. (Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J) J Clin Oncol 2021 Jun 20;39(18):1971-1982 PMID: 33905264 PMCID: PMC8260905 SCOPUS ID: 2-s2.0-85108386444 04/28/2021 78 CitationsThe Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. (Hsu JW, Farhadfar N, Murthy H, Logan BR, Bo-Subait S, Frey N, Goldstein SC, Horowitz MM, Lazarus H, Schwanke JD, Shah NN, Spellman SR, Switzer GE, Devine SM, Shaw BE, Wingard JR) Transplant Cell Ther 2021 Jun;27(6):507-516 PMID: 33865804 PMCID: PMC8217124 SCOPUS ID: 2-s2.0-85108052714 04/19/2021 25 CitationsSerious Adverse Events in Related Donors: A Report from the Related Donor Safe Study. (Seftel MD, Chitphakdithai P, Miller JP, Kobusingye H, Logan BR, Linenberger M, Artz AS, Haight AE, Jacobsohn DA, Litzow MR, Magalhaes-Silverman M, Selby GB, Vusirikala M, Horowitz MM, Switzer GE, Confer DL, Shaw BE, Pulsipher MA) Transplant Cell Ther 2021 Apr;27(4):352.e1-352.e5 PMID: 33836890 PMCID: PMC8036235 SCOPUS ID: 2-s2.0-85101149566 04/11/2021 3 CitationsWorldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. (El Fakih R, Greinix H, Koh M, Shaw B, Mohty M, Al Nahedh M, Saber W, Kharfan-Dabaja MA, Perales MA, Savani BN, Majhail NS, Passweg JR, Sureda A, Ahmed SO, Gluckman E, Riches M, El-Jawahri A, Rondelli D, Srivastava A, Faulkner L, Atsuta Y, Ballen KK, Rasheed W, Okamoto S, Seber A, Chao N, Kröger N, Kodera Y, Szer J, Hashmi SK, Horowitz MM, Weisdorf D, Niederwieser D, Aljurf M) Transplant Cell Ther 2021 Mar;27(3):267.e1-267.e5 PMID: 33781535 SCOPUS ID: 2-s2.0-85101137848 03/31/2021 4 CitationsMyeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial. (Scott BL, Pasquini MC, Fei M, Fraser R, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick E, Fernandez HF, Soiffer RJ, Alyea E, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Hourigan CS, Gui G, Mendizabal A, Horowitz MM, Deeg HJ, Horwitz ME) Transplant Cell Ther 2021 Jun;27(6):483.e1-483.e6 PMID: 33775615 PMCID: PMC8217373 SCOPUS ID: 2-s2.0-85106302930 03/30/2021 57 CitationsDouble unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. (Fuchs EJ, O'Donnell PV, Eapen M, Logan B, Antin JH, Dawson P, Devine S, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG) Blood 2021 Jan 21;137(3):420-428 PMID: 33475736 PMCID: PMC7819761 SCOPUS ID: 2-s2.0-85092507677 01/22/2021 115 CitationsBuilding a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies. (Devine SM, Horowitz MM) J Clin Oncol 2021 Feb 10;39(5):534-544 PMID: 33434065 PMCID: PMC8443822 SCOPUS ID: 2-s2.0-85102054855 01/13/2021 6 CitationsAssessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial. (Atallah E, Schiffer CA, Radich JP, Weinfurt KP, Zhang MJ, Pinilla-Ibarz J, Kota V, Larson RA, Moore JO, Mauro MJ, Deininger MWN, Thompson JE, Oehler VG, Wadleigh M, Shah NP, Ritchie EK, Silver RT, Cortes J, Lin L, Visotcky A, Baim A, Harrell J, Helton B, Horowitz M, Flynn KE) JAMA Oncol 2021 Jan 01;7(1):42-50 PMID: 33180106 PMCID: PMC7662490 SCOPUS ID: 2-s2.0-85096163350 11/13/2020 50 CitationsReal-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. (Pasquini MC, Hu ZH, Curran K, Laetsch T, Locke F, Rouce R, Pulsipher MA, Phillips CL, Keating A, Frigault MJ, Salzberg D, Jaglowski S, Sasine JP, Rosenthal J, Ghosh M, Landsburg D, Margossian S, Martin PL, Kamdar MK, Hematti P, Nikiforow S, Turtle C, Perales MA, Steinert P, Horowitz MM, Moskop A, Pacaud L, Yi L, Chawla R, Bleickardt E, Grupp S) Blood Adv 2020 Nov 10;4(21):5414-5424 PMID: 33147337 PMCID: PMC7656920 SCOPUS ID: 2-s2.0-85096931359 11/05/2020 256 CitationsHematopoietic Cell Transplantation: Practice Predictions for the Year 2023. (Farhadfar N, Burns LJ, Mupfudze T, Shaw BE, Bollard CM, Devine SM, Horowitz MM, Jones RJ, Murthy HS, Wingard JR, Lee SJ) Transplant Cell Ther 2021 Feb;27(2):183.e1-183.e7 PMID: 33045387 PMCID: PMC7546661 SCOPUS ID: 2-s2.0-85096828571 10/13/2020 6 CitationsHealth-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study. (Switzer GE, Bruce JG, Kiefer DM, Kobusingye H, Abebe KZ, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA) Biol Blood Marrow Transplant 2020 Dec;26(12):2365-2371 PMID: 32829080 PMCID: PMC7686016 SCOPUS ID: 2-s2.0-85091208680 08/24/2020 5 CitationsReal-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. (Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, Wood WA, Brazauskas R, Lehmann L, Pasquini MC, Seber A, Lu PH, Atsuta Y, Riches M, Perales MA, Worel N, Okamoto S, Srivastava A, Chemaly RF, Cordonnier C, Dandoy CE, Wingard JR, Kharfan-Dabaja MA, Hamadani M, Majhail NS, Waghmare AA, Chao N, Kröger N, Shaw B, Mohty M, Niederwieser D, Greinix H, Hashmi SK, WBMT and the CIBMTR Health Services and International Studies Committee) Biol Blood Marrow Transplant 2020 Dec;26(12):2181-2189 PMID: 32717432 PMCID: PMC7380217 SCOPUS ID: 2-s2.0-85089451061 07/28/2020 48 CitationsIxazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2020 Oct;26(10):1876-1885 PMID: 32653622 PMCID: PMC7571859 SCOPUS ID: 2-s2.0-85089134303 07/13/2020 4 CitationsCancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer. (Annapragada A, Sikora A, Bollard C, Conejo-Garcia J, Cruz CR, Demehri S, Demetriou M, Demirdjian L, Fong L, Horowitz M, Hutson A, Kadash-Edmondson K, Kufe D, Lipkin S, Liu S, McCarthy C, Morgan M, Morris Z, Pan Y, Pasquini M, Schoenberger S, Van Allen E, Vilar E, Xing Y, Zha W, IOTN Consortium, Odunsi A) J Immunother Cancer 2020 Jun;8(1) PMID: 32554617 PMCID: PMC7304845 SCOPUS ID: 2-s2.0-85086691799 06/20/2020 8 CitationsHLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation. (Petersdorf EW, Stevenson P, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Carrington M) Blood 2020 Jul 16;136(3):362-369 PMID: 32483623 PMCID: PMC7365916 SCOPUS ID: 2-s2.0-85088276743 06/03/2020 31 CitationsRole of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation. (Petersdorf EW, Bengtsson M, De Santis D, Dubois V, Fleischhauer K, Gooley T, Horowitz M, Madrigal JA, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Stevenson P, Carrington M, the, International Histocompatibility Working Group in Hematopoietic-Cell Transplantation) J Clin Oncol 2020 Aug 20;38(24):2712-2718 PMID: 32479188 PMCID: PMC7430213 SCOPUS ID: 2-s2.0-85089708521 06/02/2020 40 CitationsTocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? (Frigault MJ, Nikiforow S, Mansour MK, Hu ZH, Horowitz MM, Riches ML, Hematti P, Turtle CJ, Zhang MJ, Perales MA, Pasquini MC) Blood 2020 Jul 02;136(1):137-139 PMID: 32457999 PMCID: PMC7332891 SCOPUS ID: 2-s2.0-85087529450 05/28/2020 53 CitationsCurrent Use of and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Aug;26(8):e177-e182 PMID: 32438042 PMCID: PMC7404814 SCOPUS ID: 2-s2.0-85085969206 05/22/2020 317 CitationsHematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. (Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):e161-e166 PMID: 32389803 PMCID: PMC7206419 SCOPUS ID: 2-s2.0-85084668943 05/12/2020 38 CitationsGraft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. (Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):1312-1317 PMID: 32283185 PMCID: PMC7194895 SCOPUS ID: 2-s2.0-85083795044 04/14/2020 49 CitationsThe Changing Landscape of Treatment in Acute Myeloid Leukemia. (Koenig K, Mims A, Levis MJ, Horowitz MM) Am Soc Clin Oncol Educ Book 2020 Mar;40:1-12 PMID: 32239961 04/03/2020 Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. (Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW) Blood Adv 2020 Feb 11;4(3):467-476 PMID: 32027744 PMCID: PMC7013267 SCOPUS ID: 2-s2.0-85082178004 02/07/2020 37 CitationsComparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study. (Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, Champlin R, Nishihori T, Confer D, Gajewski J, Farnia S, Greenberg P, Warlick E, Weisdorf D, Saber W, Horowitz MM, Rizzo JD) JAMA Oncol 2020 Apr 01;6(4):486-493 PMID: 31830234 PMCID: PMC6990739 SCOPUS ID: 2-s2.0-85076620276 12/13/2019 39 CitationsRandomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial. (Pidala J, Hamadani M, Dawson P, Martens M, Alousi AM, Jagasia M, Efebera YA, Chhabra S, Pusic I, Holtan SG, Ferrara JLM, Levine JE, Mielcarek M, Anasetti C, Antin JH, Bolaños-Meade J, Howard A, Logan BR, Leifer ES, Pritchard TS, Horowitz MM, MacMillan ML) Blood 2020 Jan 09;135(2):97-107 PMID: 31738834 PMCID: PMC6952830 SCOPUS ID: 2-s2.0-85077761109 11/19/2019 55 CitationsRole of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study. (Petersdorf EW, Carrington M, O'hUigin C, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA, Maiers MJ, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Stevenson P, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Lancet Haematol 2020 Jan;7(1):e50-e60 PMID: 31669248 PMCID: PMC6948919 SCOPUS ID: 2-s2.0-85076685183 11/02/2019 51 CitationsCorrection: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries. (Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK, Seber A, Saber W, Kharfan-Dabaja MA, Rasheed W, Okamoto S, Khera N, Wood WA, Koh MBC, Greinix H, Kodera Y, Szer J, Horowitz MM, Weisdorf D, Aljurf M) Bone Marrow Transplant 2020 Apr;55(4):837 PMID: 31616063 SCOPUS ID: 2-s2.0-85074047416 10/17/2019 Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation. (Pidala J, Martens M, Anasetti C, Carreras J, Horowitz M, Lee SJ, Antin J, Cutler C, Logan B) JAMA Oncol 2020 Jan 01;6(1):e192974 PMID: 31556923 PMCID: PMC6763979 SCOPUS ID: 2-s2.0-85072756041 09/27/2019 13 CitationsWorldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries. (Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK, Seber A, Saber W, Kharfan-Dabaja MA, Rasheed W, Okamoto S, Khera N, Wood WA, Koh MBC, Greinix H, Kodera Y, Szer J, Horowitz MM, Weisdorf D, Aljurf M) Bone Marrow Transplant 2020 Apr;55(4):698-707 PMID: 31484992 SCOPUS ID: 2-s2.0-85073779919 09/06/2019 4 CitationsWorldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations. (Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas M, Ahmed SO, Novitzky N, Srivastava A, Seber A, Elsolh H, Ghavamzadeh A, Confer D, Kodera Y, Greinix H, Szer J, Horowitz M, Niederwieser D) Hematol Oncol Stem Cell Ther 2020 Mar;13(1):7-16 PMID: 31449781 SCOPUS ID: 2-s2.0-85080069497 08/27/2019 12 CitationsAllogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial. (Ambinder RF, Wu J, Logan B, Durand CM, Shields R, Popat UR, Little RF, McMahon DK, Cyktor J, Mellors JW, Ayala E, Kaplan LD, Noy A, Jones RJ, Howard A, Forman SJ, Porter D, Arce-Lara C, Shaughnessy P, Sproat L, Hashmi SK, Mendizabal AM, Horowitz MM, Navarro WH, Alvarnas JC) Biol Blood Marrow Transplant 2019 Nov;25(11):2160-2166 PMID: 31279752 PMCID: PMC6907401 SCOPUS ID: 2-s2.0-85069900077 07/08/2019 27 CitationsFLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical? (Levis MJ, Chen YB, Hamadani M, Horowitz MM, Jones RJ, Blood and Marrow Transplant Clinical Trials Network) J Clin Oncol 2019 Jul 01;37(19):1604-1607 PMID: 31034300 PMCID: PMC6804888 SCOPUS ID: 2-s2.0-85068884815 04/30/2019 25 CitationsWorldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations. (Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D) Biol Blood Marrow Transplant 2019 Dec;25(12):2330-2337 PMID: 31002990 SCOPUS ID: 2-s2.0-85065760511 04/20/2019 16 CitationsPlerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. (Chen YB, Le-Rademacher J, Brazauskas R, Kiefer DM, Hamadani M, DiPersio JF, Litzow MR, Craig M, Horwitz ME, Artz AS, McClune BL, Fernandez HF, Duong HK, Kobusingye H, Proue M, Drexler RJ, Horowitz MM, Shaw BE, Miller JP, Hosoba S, Waller EK, Devine SM) Blood Adv 2019 Mar 26;3(6):875-883 PMID: 30890544 PMCID: PMC6436017 SCOPUS ID: 2-s2.0-85072746485 03/21/2019 26 CitationsThree prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). (Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J) Lancet Haematol 2019 Mar;6(3):e132-e143 PMID: 30824040 PMCID: PMC6503965 SCOPUS ID: 2-s2.0-85061920512 03/03/2019 185 Citations"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries". (Aljurf M, Weisdorf D, Alfraih F, Szer J, Müller C, Confer D, Hashmi S, Kröger N, Shaw BE, Greinix H, Kharfan-Dabaja MA, Foeken L, Seber A, Ahmed S, El-Jawahri A, Al-Awwami M, Atsuta Y, Pasquini M, Hanbali A, Alzahrani H, Okamoto S, Gluckman E, Mohty M, Kodera Y, Horowitz M, Niederwieser D, El Fakih R) Bone Marrow Transplant 2019 Aug;54(8):1179-1188 PMID: 30778127 PMCID: PMC6760540 SCOPUS ID: 2-s2.0-85061755380 02/20/2019 42 CitationsAutologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. (Stadtmauer EA, Pasquini MC, Blackwell B, Hari P, Bashey A, Devine S, Efebera Y, Ganguly S, Gasparetto C, Geller N, Horowitz MM, Koreth J, Knust K, Landau H, Brunstein C, McCarthy P, Nelson C, Qazilbash MH, Shah N, Vesole DH, Vij R, Vogl DT, Giralt S, Somlo G, Krishnan A) J Clin Oncol 2019 Mar 01;37(7):589-597 PMID: 30653422 PMCID: PMC6553842 SCOPUS ID: 2-s2.0-85064136756 01/18/2019 177 CitationsHigher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE) Biol Blood Marrow Transplant 2019 May;25(5):955-964 PMID: 30605731 PMCID: PMC6511296 SCOPUS ID: 2-s2.0-85061429566 01/04/2019 7 CitationsEffect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. (Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2019 Apr;25(4):699-711 PMID: 30423480 PMCID: PMC6453753 SCOPUS ID: 2-s2.0-85058455309 11/14/2018 11 CitationsRelated peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE) Haematologica 2019 Apr;104(4):844-854 PMID: 30381298 PMCID: PMC6442962 SCOPUS ID: 2-s2.0-85064008651 11/02/2018 12 CitationsShould an HLA-matched donor still be considered the perfect donor? (Jones RJ, Horowitz MM) Lancet Haematol 2018 Sep;5(9):e388-e390 PMID: 30172342 SCOPUS ID: 2-s2.0-85052468144 09/03/2018 3 CitationsHematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity. (Eapen M, Brazauskas R, Hemmer M, Perez WS, Steinert P, Horowitz MM, Deeg HJ) Blood Adv 2018 Aug 28;2(16):2095-2103 PMID: 30135184 PMCID: PMC6113615 SCOPUS ID: 2-s2.0-85056694237 08/24/2018 59 CitationsNarrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. (Baldomero H, Aljurf M, Zaidi SZA, Hashmi SK, Ghavamzadeh A, Elhaddad A, Hamladji RM, Ahmed P, Torjemane L, Abboud M, Tbakhi A, Khabori MA, El Quessar A, Bazuaye N, Bekadja MA, Adil S, Fahmy O, Ramzi M, Ibrahim A, Alseraihy A, Ben Abdejalil N, Sarhan M, Huneini MA, Mahmal L, ElSolh H, Hussain F, Nassar A, Al-Hashmi H, Hamidieh AA, Pasquini M, Kodera Y, Kröger N, Mohty M, Jaimovich G, Rolon JM, Paulson K, Greinix H, Weisdorf D, Horowitz M, Nunez J, Gratwohl A, Passweg J, Koh M, Szer J, Niederwieser D, Novitzky N, East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)) Bone Marrow Transplant 2019 Mar;54(3):402-417 PMID: 30082852 PMCID: PMC6363888 SCOPUS ID: 2-s2.0-85052538993 08/08/2018 30 CitationsUpper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated. (Nikiforow S, Wang T, Hemmer M, Spellman S, Akpek G, Antin JH, Choi SW, Inamoto Y, Khoury HJ, MacMillan M, Marks DI, Meehan K, Nakasone H, Nishihori T, Olsson R, Paczesny S, Przepiorka D, Reddy V, Reshef R, Schoemans H, Waller N, Weisdorf D, Wirk B, Horowitz M, Alousi A, Couriel D, Pidala J, Arora M, Cutler C, GV12-02 Writing Committee on behalf of the CIBMTR® Graft-versus-Host Disease Working Committee) Haematologica 2018 Oct;103(10):1708-1719 PMID: 30076185 PMCID: PMC6165812 SCOPUS ID: 2-s2.0-85054344409 08/05/2018 7 CitationsTranslation of Clinical Research into Practice: An Impact Assessment of the Results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization. (Khera N, Mau LW, Denzen EM, Meyer C, Houg K, Lee SJ, Horowitz MM, Burns LJ) Biol Blood Marrow Transplant 2018 Nov;24(11):2204-2210 PMID: 29966761 PMCID: PMC6242749 SCOPUS ID: 2-s2.0-85050809696 07/04/2018 11 CitationsA phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801. (Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M, BMT CTN.) Haematologica 2018 Nov;103(11):1915-1924 PMID: 29954931 PMCID: PMC6278959 SCOPUS ID: 2-s2.0-85055802370 06/30/2018 30 CitationsRisk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. (Strouse C, Zhang Y, Zhang MJ, DiGilio A, Pasquini M, Horowitz MM, Lee S, Ho V, Ramanathan M, Chinratanalab W, Loren A, Burns LJ, Artz A, Villa KF, Saber W) Biol Blood Marrow Transplant 2018 Oct;24(10):2072-2080 PMID: 29928989 PMCID: PMC6239945 SCOPUS ID: 2-s2.0-85054166744 06/22/2018 53 CitationsFemale Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation. (Bhatt NS, Brazauskas R, Tecca HR, Vogel J, Mattila D, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE) J Pediatr Hematol Oncol 2019 Apr;41(3):233-237 PMID: 29923857 PMCID: PMC6301126 SCOPUS ID: 2-s2.0-85049213444 06/21/2018 6 CitationsBeyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. (Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM) Lancet Haematol 2018 Nov;5(11):e563-e598 PMID: 29907552 PMCID: PMC6261436 SCOPUS ID: 2-s2.0-85048309335 06/17/2018 93 CitationsPatient HLA Germline Variation and Transplant Survivorship. (Petersdorf EW, Stevenson P, Malkki M, Strong RK, Spellman SR, Haagenson MD, Horowitz MM, Gooley T, Wang T) J Clin Oncol 2018 Aug 20;36(24):2524-2531 PMID: 29902106 PMCID: PMC6097831 SCOPUS ID: 2-s2.0-85051787496 06/15/2018 11 CitationsRepurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. (Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD) BMC Cancer 2018 May 24;18(1):593 PMID: 29793446 PMCID: PMC5968588 SCOPUS ID: 2-s2.0-85047544800 05/26/2018 28 CitationsEasy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study. (Spellecy R, Tarima S, Denzen E, Moore H, Abhyankar S, Dawson P, Foley A, Gersten I, Horwitz M, Idossa L, Joffe S, Kamani N, King R, Lazaryan A, Morris L, Horowitz MM, Majhail NS) Biol Blood Marrow Transplant 2018 Oct;24(10):2145-2151 PMID: 29679770 PMCID: PMC6193865 SCOPUS ID: 2-s2.0-85047348782 04/22/2018 15 CitationsEpidemiology and biology of relapse after stem cell transplantation. (Horowitz M, Schreiber H, Elder A, Heidenreich O, Vormoor J, Toffalori C, Vago L, Kröger N) Bone Marrow Transplant 2018 Nov;53(11):1379-1389 PMID: 29670211 PMCID: PMC6282701 SCOPUS ID: 2-s2.0-85045618745 04/20/2018 84 CitationsDesign and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia. (Atallah E, Schiffer CA, Weinfurt KP, Zhang MJ, Radich JP, Oehler VG, Pinilla-Ibarz J, Deininger MWN, Lin L, Larson RA, Mauro MJ, Moore JO, Ritchie EK, Shah NP, Silver RT, Wadleigh M, Cortes J, Thompson J, Guhl J, Horowitz MM, Flynn KE) BMC Cancer 2018 Apr 02;18(1):359 PMID: 29609532 PMCID: PMC5879565 SCOPUS ID: 2-s2.0-85044841612 04/04/2018 16 CitationsCohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. (Stiff PJ, Montesinos P, Peled T, Landau E, Goudsmid NR, Mandel J, Hasson N, Olesinski E, Glukhman E, Snyder DA, Cohen EG, Kidron OS, Bracha D, Harati D, Ben-Abu K, Freind E, Freedman LS, Cohen YC, Olmer L, Barishev R, Rocha V, Gluckman E, Horowitz MM, Eapen M, Nagler A, Sanz G) Biol Blood Marrow Transplant 2018 Jul;24(7):1463-1470 PMID: 29477778 PMCID: PMC6045964 SCOPUS ID: 2-s2.0-85044995501 02/27/2018 38 CitationsDevelopment of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. (Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ) Biol Blood Marrow Transplant 2018 May;24(5):1049-1056 PMID: 29454040 PMCID: PMC5953795 SCOPUS ID: 2-s2.0-85043996138 02/18/2018 94 CitationsEngaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation. (Burns LJ, Abbetti B, Arnold SD, Bender J, Doughtie S, El-Jawahiri A, Gee G, Hahn T, Horowitz MM, Johnson S, Juckett M, Krishnamurit L, Kullberg S, LeMaistre CF, Loren A, Majhail NS, Murphy EA, Rizzo D, Roche-Green A, Saber W, Schatz BA, Schmit-Pokorny K, Shaw BE, Syrjala KL, Tierney DK, Ullrich C, Vanness DJ, Wood WA, Denzen EM) Biol Blood Marrow Transplant 2018 Jun;24(6):1111-1118 PMID: 29408289 PMCID: PMC5993588 SCOPUS ID: 2-s2.0-85043400078 02/07/2018 22 CitationsDonor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. (Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, Lehmann L, MacMillan MA, McIver Z, Nishihori T, Norkin M, O'Brien T, Olsson RF, Reshef R, Saad A, Savani BN, Schouten HC, Seo S, Solh M, Verdonck L, Vij R, Wirk B, Yared J, Horowitz MM, Knight JM, Verneris MR) Bone Marrow Transplant 2018 Jul;53(7):932-937 PMID: 29382954 PMCID: PMC6041147 SCOPUS ID: 2-s2.0-85041181961 02/01/2018 2 CitationsTocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease. (Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M) Haematologica 2018 Apr;103(4):717-727 PMID: 29351985 PMCID: PMC5865423 SCOPUS ID: 2-s2.0-85044420638 01/21/2018 36 CitationsBlood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials. (Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolaños-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, Pavletic S, Perales MA, Porter D, Reshef R, Weisdorf D, Antin JH) Biol Blood Marrow Transplant 2018 Jun;24(6):1274-1280 PMID: 29325830 PMCID: PMC5993573 SCOPUS ID: 2-s2.0-85041672720 01/13/2018 39 CitationsAllogeneic Transplantation for Follicular Lymphoma: Does One Size Fit All? (Hamadani M, Horowitz MM) J Oncol Pract 2017 Dec;13(12):798-806 PMID: 29232542 PMCID: PMC5728364 SCOPUS ID: 2-s2.0-85039968023 12/13/2017 9 CitationsIntravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia. (Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI, Acute Leukemia Committee of the CIBMTR) Biol Blood Marrow Transplant 2018 Apr;24(4):726-733 PMID: 29197676 PMCID: PMC5902420 SCOPUS ID: 2-s2.0-85041917243 12/05/2017 60 CitationsInfluence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis. (Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J) Biol Blood Marrow Transplant 2018 Mar;24(3):521-528 PMID: 29155316 PMCID: PMC5826854 SCOPUS ID: 2-s2.0-85039159224 11/21/2017 33 CitationsPROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. (Shaw BE, Syrjala KL, Onstad LE, Chow EJ, Flowers ME, Jim H, Baker KS, Buckley S, Fairclough DL, Horowitz MM, Lee SJ) Cancer 2018 Feb 15;124(4):841-849 PMID: 29072787 PMCID: PMC5800994 SCOPUS ID: 2-s2.0-85032287599 10/27/2017 39 CitationsUpdated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. (Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL) Lancet Haematol 2017 Sep;4(9):e431-e442 PMID: 28826616 PMCID: PMC5718627 SCOPUS ID: 2-s2.0-85027488718 08/23/2017 129 CitationsCentralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. (Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD) Cancer 2017 Dec 01;123(23):4687-4700 PMID: 28817182 PMCID: PMC5693638 SCOPUS ID: 2-s2.0-85034085598 08/18/2017 46 CitationsUmbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. (Eapen M, Kurtzberg J, Zhang MJ, Hattersely G, Fei M, Mendizabal A, Chan KW, De Oliveira S, Schultz KR, Wall D, Horowitz MM, Wagner JE) Biol Blood Marrow Transplant 2017 Oct;23(10):1714-1721 PMID: 28684372 PMCID: PMC5605440 SCOPUS ID: 2-s2.0-85026649100 07/08/2017 20 CitationsUmbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes (Mary Eapen, Joanne Kurtzberg, Mei-Jie Zhang, Gareth Hattersely, Mingwei Fei, Adam Mendizabal, Ka Wah Chan, Satiro De Oliveira, Kirk R Schultz, Donna Wall, Mary M Horowitz, John E Wagner ) Biol Blood Marrow Transplant Eapen M, Kurtzberg J, Zhang MJ, Hattersely G, Fei M, Mendizabal A, Chan KW, De Oliveira S, Schultz KR, Wall D, Horowitz MM, Wagner JE. Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. Biol Blood Marrow Transplant. 2017 Oct;23(10):1714-1721. doi: 10.1016/j.bbmt.2017.06.023. Epub 2017 Jul 3. PMID: 28684372; PMCID: PMC5605440. 07/03/2017 Parent versus child donor perceptions of the bone marrow donation experience. (Switzer GE, Bruce J, Pastorek G, Kiefer DM, Kobusingye H, Drexler R, Besser RAM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni JW, Pulsipher MA) Bone Marrow Transplant 2017 Sep;52(9):1338-1341 PMID: 28650449 PMCID: PMC5933883 SCOPUS ID: 2-s2.0-85028813659 06/27/2017 9 CitationsAllele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. (Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle JH, Davies SM, Freeman J, Hsu KC, Fleischhauer K, Kenzey C, Kurtzberg J, Michel G, Orchard PJ, Paviglianiti A, Rocha V, Veneris MR, Volt F, Wynn R, Lee SJ, Horowitz MM, Gluckman E, Ruggeri A) Lancet Haematol 2017 Jul;4(7):e325-e333 PMID: 28623181 PMCID: PMC5699478 SCOPUS ID: 2-s2.0-85020732533 06/18/2017 68 CitationsRecipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. (Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M) Biol Blood Marrow Transplant 2017 Aug;23(8):1295-1302 PMID: 28412518 SCOPUS ID: 2-s2.0-85019639994 04/17/2017 8 CitationsMyeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. (Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal AM, Horowitz MM, Deeg HJ, Horwitz ME) J Clin Oncol 2017 Apr 10;35(11):1154-1161 PMID: 28380315 PMCID: PMC5455603 SCOPUS ID: 2-s2.0-85017300040 04/06/2017 467 CitationsAllogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. (Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, De Lima M, Saber W, Sandmaier B, Zhang MJ, Eapen M) Cancer 2017 Jun 01;123(11):2025-2034 PMID: 28117884 PMCID: PMC5445001 SCOPUS ID: 2-s2.0-85019595123 01/25/2017 43 CitationsGraft-versus-leukemia effect of allogeneic bone marrow transplantation: Clinical and experimental aspects of late leukemia relapse (Truitt RL, Horowitz MM, Atasoylu AA, Drobyski WR, Johnson BD, LeFever AV) Cellular Immune Mechanisms and Tumor Dormancy 1 January 2017:111-132 SCOPUS ID: 2-s2.0-1842343134 01/01/2017 7 CitationsTransplantation for myelodysplastic syndromes: who, when, and which conditioning regimens. (Saber W, Horowitz MM) Hematology Am Soc Hematol Educ Program 2016 Dec 02;2016(1):478-484 PMID: 27913519 PMCID: PMC6142436 SCOPUS ID: 2-s2.0-85020287284 12/04/2016 33 CitationsHealth-Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni JW, Pulsipher MA) J Pediatr 2016 Nov;178:164-170.e1 PMID: 27522440 PMCID: PMC5085860 SCOPUS ID: 2-s2.0-84994322338 10/30/2016 21 CitationsHealth-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA) Biol Blood Marrow Transplant 2017 Jan;23(1):165-171 PMID: 27751935 PMCID: PMC5182103 SCOPUS ID: 2-s2.0-85006356488 10/19/2016 9 CitationsA trial of unrelated donor marrow transplantation for children with severe sickle cell disease. (Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N) Blood 2016 Nov 24;128(21):2561-2567 PMID: 27625358 PMCID: PMC5123194 SCOPUS ID: 2-s2.0-85015019083 09/15/2016 153 CitationsPatient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. (Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD) Biol Blood Marrow Transplant 2016 Dec;22(12):2256-2263 PMID: 27565521 PMCID: PMC5116244 SCOPUS ID: 2-s2.0-84992110582 08/28/2016 23 CitationsComparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C) JAMA Oncol 2016 Dec 01;2(12):1583-1589 PMID: 27532508 PMCID: PMC5145732 SCOPUS ID: 2-s2.0-85013156188 08/18/2016 95 CitationsComparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. (O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D) Bone Marrow Transplant 2016 Dec;51(12):1599-1601 PMID: 27526284 PMCID: PMC5143194 SCOPUS ID: 2-s2.0-84982085195 08/16/2016 38 CitationsPractice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians. (Wood WA, McGinn MK, Wilson D, Deal AM, Khera N, Shea TC, Devine SM, Appelbaum FR, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2016 Nov;22(11):2092-2099 PMID: 27481447 PMCID: PMC5067220 SCOPUS ID: 2-s2.0-84992417354 08/03/2016 6 CitationsSalvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft. (Epperla N, Pasquini M, Pierce K, Drobyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M) Bone Marrow Transplant 2017 Jan;52(1):147-150 PMID: 27479688 SCOPUS ID: 2-s2.0-84980370503 08/02/2016 5 CitationsThe Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation. (Steering Committee Of The Blood And Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 Oct;22(10):1747-1757 PMID: 27418009 PMCID: PMC5027144 SCOPUS ID: 2-s2.0-84992116568 07/16/2016 8 CitationsAutologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. (Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE Jr, Thompson J, Horowitz MM, Mendizabal A, Levine A, Krishnan A, Forman SJ, Navarro WH, Ambinder R) Blood 2016 Aug 25;128(8):1050-8 PMID: 27297790 PMCID: PMC5000843 SCOPUS ID: 2-s2.0-84984815928 06/15/2016 68 CitationsHuman leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research. (Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SG, Schultz K, Müller CR, Fernandez-Viña MA, Verneris MR, Horowitz MM, Arora M, Weisdorf DJ, Lee SJ) Haematologica 2016 Oct;101(10):1267-1274 PMID: 27247320 PMCID: PMC5046657 SCOPUS ID: 2-s2.0-84989295930 06/02/2016 16 CitationsCan we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. (Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE) Bone Marrow Transplant 2016 Sep;51(9):1173-9 PMID: 27159181 SCOPUS ID: 2-s2.0-84966474594 05/10/2016 34 CitationsValidation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation. (Arora M, Lee SJ, Spellman SR, Weisdorf DJ, Guan W, Haagenson M, Wang T, Horowitz MH, Verneris MR, Fleischhauer K, Hsu K, Thyagarajan B) Biol Blood Marrow Transplant 2016 Aug;22(8):1531-1532 PMID: 27155583 PMCID: PMC5364725 SCOPUS ID: 2-s2.0-84973534412 05/08/2016 6 CitationsReduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. (Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 Aug;22(8):1440-1448 PMID: 27118571 PMCID: PMC4949103 SCOPUS ID: 2-s2.0-84973901396 04/28/2016 40 CitationsDefibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research. (Strouse C, Richardson P, Prentice G, Korman S, Hume R, Nejadnik B, Horowitz MM, Saber W) Biol Blood Marrow Transplant 2016 Jul;22(7):1306-1312 PMID: 27108694 PMCID: PMC4914048 SCOPUS ID: 2-s2.0-84975267606 04/26/2016 45 CitationsThe Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children. (Saber W, Zhang MJ, Steinert P, Chen M, Horowitz MM) Biol Blood Marrow Transplant 2016 Aug;22(8):1460-1466 PMID: 27090960 PMCID: PMC4949099 SCOPUS ID: 2-s2.0-84973879084 04/20/2016 6 CitationsHematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. (Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, Bouzas LF, Confer D, Greinix H, Horowitz M, Iida M, Lipton J, Mohty M, Novitzky N, Nunez J, Passweg J, Pasquini MC, Kodera Y, Apperley J, Seber A, Gratwohl A) Bone Marrow Transplant 2016 Jun;51(6):778-85 PMID: 26901703 PMCID: PMC4889523 SCOPUS ID: 2-s2.0-84959109035 02/24/2016 239 CitationsProceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. (Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy DC, Huang XJ, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller J, June C, Ai HS, Luznik L, Mavilio D, Lugli E, van den Brink MRM, Champlin RE, Ciurea SO) Biol Blood Marrow Transplant 2016 Apr;22(4):594-604 PMID: 26806585 PMCID: PMC7104805 SCOPUS ID: 2-s2.0-84960481145 01/26/2016 9 CitationsGlobal Use of Peripheral Blood vs Bone Marrow as Source of Stem Cells for Allogeneic Transplantation in Patients With Bone Marrow Failure. (Yoshimi A, Baldomero H, Horowitz M, Szer J, Niederwieser D, Gratwohl A, Kodera Y, Worldwide Network of Blood and Marrow Transplantation (WBMT)) JAMA 2016 Jan 12;315(2):198-200 PMID: 26757470 SCOPUS ID: 2-s2.0-84954547071 01/13/2016 17 CitationsUses and Growth of Hematopoietic Cell Transplantation (Horowitz MM) Thomas' Hematopoietic Cell Transplantation: Fifth Edition 1 January 2016;1-2:8-17 SCOPUS ID: 2-s2.0-84979938855 01/01/2016 9 CitationsCyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study. (Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME, McCarty J, Nakamura R, Pulsipher MA, Rowley S, Leifer E, Carter SL, DiFronzo NL, Horowitz MM, Confer D, Deeg HJ, Eapen M) Lancet Haematol 2015 Sep;2(9):e367-75 PMID: 26685770 PMCID: PMC4861234 SCOPUS ID: 2-s2.0-84954025938 12/22/2015 65 CitationsOne million haemopoietic stem-cell transplants: a retrospective observational study. (Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, Gratwohl M, Bouzas LF, Confer D, Frauendorfer K, Gluckman E, Greinix H, Horowitz M, Iida M, Lipton J, Madrigal A, Mohty M, Noel L, Novitzky N, Nunez J, Oudshoorn M, Passweg J, van Rood J, Szer J, Blume K, Appelbaum FR, Kodera Y, Niederwieser D, Worldwide Network for Blood and Marrow Transplantation (WBMT)) Lancet Haematol 2015 Mar;2(3):e91-100 PMID: 26687803 SCOPUS ID: 2-s2.0-84930322558 12/22/2015 302 CitationsPhase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. (Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, Champlin RE, Chen YB, Vij R, Slack J, Soiffer RJ, Larson RA, Shea TC, Hars V, Sibley AB, Giralt S, Carter S, Horowitz MM, Linker C, Alyea EP) J Clin Oncol 2015 Dec 10;33(35):4167-75 PMID: 26527780 PMCID: PMC4658453 SCOPUS ID: 2-s2.0-84957545248 11/04/2015 127 CitationsThe effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. (Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M) Blood 2016 Jan 14;127(2):260-7 PMID: 26527675 PMCID: PMC4713163 SCOPUS ID: 2-s2.0-84955452671 11/04/2015 233 CitationsPatient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). (Wood WA, Le-Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ) Cancer 2016 Jan 01;122(1):91-8 PMID: 26439325 PMCID: PMC4707096 SCOPUS ID: 2-s2.0-84947968582 10/07/2015 54 CitationsInfections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. (Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JWM, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C, Blood and Marrow Transplant Clinical Trials Network Trial 0201) Biol Blood Marrow Transplant 2016 Feb;22(2):359-370 PMID: 26409243 PMCID: PMC4716871 SCOPUS ID: 2-s2.0-84958602733 09/27/2015 121 CitationsHigh HLA-DP Expression and Graft-versus-Host Disease. (Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P) N Engl J Med 2015 Aug 13;373(7):599-609 PMID: 26267621 PMCID: PMC4560117 SCOPUS ID: 2-s2.0-84941622235 08/13/2015 217 CitationsIn Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. (Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC Jr, Bennett JM, Benz EJ Jr, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ Jr, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA) Mayo Clin Proc 2015 Aug;90(8):996-1000 PMID: 26211600 PMCID: PMC5365030 SCOPUS ID: 2-s2.0-84938744306 07/28/2015 128 CitationsHaploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. (Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM, Fowler DH, Luznik L, Nakamura R, O'Donnell PV, Perales MA, Pingali SR, Porter DL, Riches MR, Ringdén OT, Rocha V, Vij R, Weisdorf DJ, Champlin RE, Horowitz MM, Fuchs EJ, Eapen M) Blood 2015 Aug 20;126(8):1033-40 PMID: 26130705 PMCID: PMC4543223 SCOPUS ID: 2-s2.0-84940039514 07/02/2015 517 CitationsComparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial. (Khera N, Majhail NS, Brazauskas R, Wang Z, He N, Aljurf MD, Akpek G, Atsuta Y, Beattie S, Bredeson CN, Burns LJ, Dalal JD, Freytes CO, Gupta V, Inamoto Y, Lazarus HM, LeMaistre CF, Steinberg A, Szwajcer D, Wingard JR, Wirk B, Wood WA, Joffe S, Hahn TE, Loberiza FR, Anasetti C, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2015 Oct;21(10):1815-22 PMID: 26071866 PMCID: PMC4568172 SCOPUS ID: 2-s2.0-84941315341 06/15/2015 12 CitationsNational Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report. (Martin PJ, Lee SJ, Przepiorka D, Horowitz MM, Koreth J, Vogelsang GB, Walker I, Carpenter PA, Griffith LM, Akpek G, Mohty M, Wolff D, Pavletic SZ, Cutler CS) Biol Blood Marrow Transplant 2015 Aug;21(8):1343-59 PMID: 25985921 PMCID: PMC4506719 SCOPUS ID: 2-s2.0-84937709873 05/20/2015 90 CitationsSafety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. (Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, Palmer J, Pasquini M, Rizzo DJ, Saber W, Hari P, Fenske TS) Bone Marrow Transplant 2015 Jul;50(7):947-53 PMID: 25867651 PMCID: PMC4490016 SCOPUS ID: 2-s2.0-84934795677 04/14/2015 33 CitationsProspective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. (Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC) Biol Blood Marrow Transplant 2015 Aug;21(8):1479-87 PMID: 25862591 PMCID: PMC4512746 SCOPUS ID: 2-s2.0-84937713457 04/12/2015 162 CitationsIntegration of hematopoietic cell transplantation outcomes data : Data standards are not enough (Renner R, Carlis J, Maiers M, Rizzo JD, O’Neill C, Horowitz M, Gee K, Confer D) Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 2015;9162:139-146 SCOPUS ID: 2-s2.0-84947233287 01/01/2015 2 CitationsBone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE) J Clin Oncol 2015 Feb 01;33(4):364-9 PMID: 25534391 PMCID: PMC4302216 SCOPUS ID: 2-s2.0-84921903392 12/24/2014 45 CitationsComparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. (Copelan EA, Avalos BR, Ahn KW, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI, Waller EK, Savani BN, Costa LJ, Ramanathan M, Cahn JY, Khoury HJ, Weisdorf DJ, Inamoto Y, Kamble RT, Schouten HC, Wirk B, Litzow MR, Aljurf MD, van Besien KW, Ustun C, Bolwell BJ, Bredeson CN, Fasan O, Ghosh N, Horowitz MM, Arora M, Szer J, Loren AW, Alyea EP, Cortes J, Maziarz RT, Kalaycio ME, Saber W) Biol Blood Marrow Transplant 2015 Mar;21(3):552-8 PMID: 25528388 PMCID: PMC4329042 SCOPUS ID: 2-s2.0-84922826985 12/22/2014 10 CitationsCenter for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. (Arora M, Hemmer MT, Ahn KW, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y, Weisdorf DJ, Li P, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola LM, Jacobsohn DA, Jagasia M, Klumpp TR, Petersdorf EW, Santarone S, Schouten HC, Wingard JR, Spellman SR, Pavletic SZ, Lee SJ, Horowitz MM, Flowers ME) Biol Blood Marrow Transplant 2015 Apr;21(4):640-5 PMID: 25528390 PMCID: PMC4359642 SCOPUS ID: 2-s2.0-84924296139 12/22/2014 23 CitationsIncreasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. (Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ, Graft-vs-Host Disease Working Committee of the CIBMTR) Biol Blood Marrow Transplant 2015 Feb;21(2):266-74 PMID: 25445023 PMCID: PMC4326247 SCOPUS ID: 2-s2.0-84920903701 12/03/2014 308 CitationsBlood and marrow transplant clinical trials network state of the Science Symposium 2014. (Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM) Biol Blood Marrow Transplant 2015 Feb;21(2):202-24 PMID: 25445636 PMCID: PMC4426907 SCOPUS ID: 2-s2.0-84920914015 12/03/2014 19 CitationsOne-unit versus two-unit cord-blood transplantation for hematologic cancers. (Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2014 Oct 30;371(18):1685-94 PMID: 25354103 PMCID: PMC4257059 SCOPUS ID: 2-s2.0-84908406651 10/30/2014 231 CitationsImpact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia. (Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn JY, Cairo MS, Cutler CS, Flowers ME, Gale RP, Herzig R, Isola LM, Jacobsohn DA, Jagasia MH, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Spellman SR, Schouten HC, Verdonck LF, Wingard JR, Weisdorf DJ, Horowitz MM, Pavletic SZ) Clin Cancer Res 2015 May 01;21(9):2020-8 PMID: 25348512 PMCID: PMC4411210 SCOPUS ID: 2-s2.0-84935449959 10/29/2014 96 CitationsHLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. (Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T, Haagenson MD, Horowitz MM, Hsu K, Jindra P, Madrigal A, Oudshoorn M, Ringdén O, Schroeder ML, Spellman SR, Tiercy JM, Velardi A, Witt CS, O'Huigin C, Apps R, Carrington M, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Blood 2014 Dec 18;124(26):3996-4003 PMID: 25323824 PMCID: PMC4271183 SCOPUS ID: 2-s2.0-84919465848 10/18/2014 124 CitationsRecommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Howard CA, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG, Pasquini MC, Spellman SR) Biol Blood Marrow Transplant 2015 Jan;21(1):4-7 PMID: 25278457 PMCID: PMC4272893 SCOPUS ID: 2-s2.0-84924246712 10/04/2014 76 CitationsPhase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT) Blood 2014 Nov 20;124(22):3221-7; quiz 3335 PMID: 25170121 PMCID: PMC4239331 SCOPUS ID: 2-s2.0-84911435257 08/30/2014 84 CitationsNonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. (Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C) Blood 2014 Oct 16;124(16):2596-606 PMID: 25161269 PMCID: PMC4199961 SCOPUS ID: 2-s2.0-84908131214 08/28/2014 214 CitationsHLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. (Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M) N Engl J Med 2014 Jul 24;371(4):339-48 PMID: 25054717 PMCID: PMC5965695 SCOPUS ID: 2-s2.0-84904566576 07/24/2014 777 CitationsTacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. (Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, Carter SL, Horowitz MM, Antin JH) Blood 2014 Aug 21;124(8):1372-7 PMID: 24982504 PMCID: PMC4141519 SCOPUS ID: 2-s2.0-84907357105 07/02/2014 151 CitationsMulticenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. (Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS) Biol Blood Marrow Transplant 2014 Oct;20(10):1566-72 PMID: 24972249 PMCID: PMC4169902 SCOPUS ID: 2-s2.0-84912532203 06/28/2014 14 CitationsExercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. (Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1530-6 PMID: 24910380 PMCID: PMC4163109 SCOPUS ID: 2-s2.0-84912532936 06/10/2014 67 CitationsChallenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. (Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM) Bone Marrow Transplant 2014 Aug;49(8):1016-21 PMID: 24777183 SCOPUS ID: 2-s2.0-84905686615 04/30/2014 23 CitationsValidation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. (Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W) Blood 2014 Jun 05;123(23):3664-71 PMID: 24744269 PMCID: PMC4047501 SCOPUS ID: 2-s2.0-84905902438 04/20/2014 699 CitationsRandomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. (Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, Cooke KR) Biol Blood Marrow Transplant 2014 Jun;20(6):858-64 PMID: 24607553 PMCID: PMC4128626 SCOPUS ID: 2-s2.0-84899920388 03/13/2014 59 CitationsGraft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. (Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)) Biol Blood Marrow Transplant 2014 May;20(5):662-7 PMID: 24525277 PMCID: PMC4071962 SCOPUS ID: 2-s2.0-84897957526 02/15/2014 22 CitationsImpact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. (Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V, Center for International Blood and Marrow Transplant Research, Netcord, Eurocord, and the European Group for Blood and Marrow Transplantation) Blood 2014 Jan 02;123(1):133-40 PMID: 24141369 PMCID: PMC3879902 SCOPUS ID: 2-s2.0-84891778061 10/22/2013 212 CitationsBetter leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. (Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn JY, Costa LJ, de Lima M, Gale RP, Hale GA, Halter J, Hamadani M, Inamoto Y, Kamble RT, Litzow MR, Loren AW, Marks DI, Olavarria E, Roy V, Sabloff M, Savani BN, Seftel M, Schouten HC, Ustun C, Waller EK, Weisdorf DJ, Wirk B, Horowitz MM, Arora M, Szer J, Cortes J, Kalaycio ME, Maziarz RT, Saber W) Blood 2013 Dec 05;122(24):3863-70 PMID: 24065243 PMCID: PMC3854108 SCOPUS ID: 2-s2.0-84891072099 09/26/2013 137 CitationsComparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. (Mauskopf J, Chirila C, Graham J, Gersten ID, Leather H, Maziarz RT, Baden LR, Bolaños-Meade J, Brown JM, Walsh TJ, Horowitz MH, Kurtzberg J, Marr KA, Wingard JR) Am J Health Syst Pharm 2013 Sep 01;70(17):1518-27 PMID: 23943184 PMCID: PMC4019750 SCOPUS ID: 2-s2.0-84899036384 08/15/2013 13 CitationsImpact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). (Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM) Blood 2013 Sep 12;122(11):1974-82 PMID: 23847196 PMCID: PMC3772501 SCOPUS ID: 2-s2.0-84887389178 07/13/2013 83 CitationsDivergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. (Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR) Biol Blood Marrow Transplant 2013 Sep;19(9):1368-73 PMID: 23806770 SCOPUS ID: 2-s2.0-84882809747 06/29/2013 27 CitationsRole of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. (Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L, Cazzola M, Park S, Itzykson R, Ades L, Fenaux P, Jadersten M, Hellstrom-Lindberg E, Gale RP, Beach CL, Lee SJ, Horowitz MM, Greenberg PL, Tallman MS, DiPersio JF, Bunjes D, Weisdorf DJ, Cutler C) J Clin Oncol 2013 Jul 20;31(21):2662-70 PMID: 23797000 PMCID: PMC3825320 SCOPUS ID: 2-s2.0-84883553488 06/26/2013 229 CitationsMultiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. (Fernández-Viña MA, Klein JP, Haagenson M, Spellman SR, Anasetti C, Noreen H, Baxter-Lowe LA, Cano P, Flomenberg N, Confer DL, Horowitz MM, Oudshoorn M, Petersdorf EW, Setterholm M, Champlin R, Lee SJ, de Lima M) Blood 2013 May 30;121(22):4603-10 PMID: 23596045 PMCID: PMC3668493 SCOPUS ID: 2-s2.0-84880775816 04/19/2013 122 CitationsAnatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration. (Giralt S, McCarthy PL, Anderson KC, Carter SL, Richardson PG, Rajkumar SV, Laport GG, Stadtmauer EA, Pasquini MC, Horowitz MM) Biol Blood Marrow Transplant 2013 Jun;19(6):858-9 PMID: 23545332 PMCID: PMC4426902 SCOPUS ID: 2-s2.0-84877878693 04/03/2013 2 CitationsQuantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. (Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D, Worldwide Network of Blood and Marrow Transplantation (WBMT)) Haematologica 2013 Aug;98(8):1282-90 PMID: 23508009 PMCID: PMC3729910 SCOPUS ID: 2-s2.0-84880968130 03/20/2013 93 CitationsPhase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial. (Vose JM, Carter S, Burns LJ, Ayala E, Press OW, Moskowitz CH, Stadtmauer EA, Mineshi S, Ambinder R, Fenske T, Horowitz M, Fisher R, Tomblyn M) J Clin Oncol 2013 May 01;31(13):1662-8 PMID: 23478060 PMCID: PMC3635682 SCOPUS ID: 2-s2.0-84884202033 03/13/2013 131 CitationsMapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation. (Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T) Blood 2013 Mar 07;121(10):1896-905 PMID: 23305741 PMCID: PMC3591807 SCOPUS ID: 2-s2.0-84876589420 01/12/2013 52 Citations2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini M, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2013:187-97 PMID: 25095508 SCOPUS ID: 2-s2.0-84906956354 01/01/2013 45 CitationsCord-blood engraftment with ex vivo mesenchymal-cell coculture. (de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, Kebriaei P, Parmar S, Popat U, Hosing C, Champlin R, Bollard C, Molldrem JJ, Jones RB, Nieto Y, Andersson BS, Shah N, Oran B, Cooper LJ, Worth L, Qazilbash MH, Korbling M, Rondon G, Ciurea S, Bosque D, Maewal I, Simmons PJ, Shpall EJ) N Engl J Med 2012 Dec 13;367(24):2305-15 PMID: 23234514 PMCID: PMC3805360 SCOPUS ID: 2-s2.0-84871071832 12/14/2012 390 CitationsDoes matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients? (Horowitz MM) Best Pract Res Clin Haematol 2012 Dec;25(4):483-6 PMID: 23200546 PMCID: PMC6432637 SCOPUS ID: 2-s2.0-84870694832 12/04/2012 24 CitationsPeripheral-blood stem cells versus bone marrow from unrelated donors. (Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2012 Oct 18;367(16):1487-96 PMID: 23075175 PMCID: PMC3816375 10/19/2012 Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. (Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ) J Clin Oncol 2012 Sep 10;30(26):3194-201 PMID: 22869882 PMCID: PMC3434978 SCOPUS ID: 2-s2.0-84866554399 08/08/2012 131 CitationsMHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation. (Petersdorf EW, Malkki M, Gooley TA, Spellman SR, Haagenson MD, Horowitz MM, Wang T) Sci Transl Med 2012 Jul 25;4(144):144ra101 PMID: 22837536 PMCID: PMC3633562 SCOPUS ID: 2-s2.0-84864509466 07/28/2012 50 CitationsEffect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. (Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, Nagler A, Navarrette C, Prasad V, Pouthier F, Price T, Ratanatharathorn V, van Rood JJ, Horowitz MM, Gluckman E, Eapen M, Eurocord-European Blood and Marrow Transplant Group and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2012 Dec;18(12):1890-6 PMID: 22814031 PMCID: PMC3826155 SCOPUS ID: 2-s2.0-84869090988 07/21/2012 65 CitationsAllogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). (Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G, Shaw BE, Schmidt AH, Fechter M, Madrigal A, Szer J, Aljurf MD, Weisdorf D, Horowitz MM, Greinix H, Niederwieser D, Gratwohl A, Kodera Y, Confer D) Bone Marrow Transplant 2013 Feb;48(2):220-5 PMID: 22773129 SCOPUS ID: 2-s2.0-84873482650 07/10/2012 36 CitationsGraft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. (Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M) Biol Blood Marrow Transplant 2012 Nov;18(11):1727-33 PMID: 22766220 PMCID: PMC3472079 SCOPUS ID: 2-s2.0-84867505772 07/07/2012 115 CitationsTransplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. (Pasquini MC, Voltarelli J, Atkins HL, Hamerschlak N, Zhong X, Ahn KW, Sullivan KM, Carrum G, Andrey J, Bredeson CN, Cairo M, Gale RP, Hahn T, Storek J, Horowitz MM, McSweeney PA, Griffith LM, Muraro PA, Pavletic SZ, Nash RA) Biol Blood Marrow Transplant 2012 Oct;18(10):1471-8 PMID: 22705497 PMCID: PMC3950896 SCOPUS ID: 2-s2.0-84866174558 06/19/2012 55 CitationsA perspective on the selection of unrelated donors and cord blood units for transplantation. (Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research) Blood 2012 Jul 12;120(2):259-65 PMID: 22596257 PMCID: PMC3398760 SCOPUS ID: 2-s2.0-84864144424 05/19/2012 125 CitationsLenalidomide after stem-cell transplantation for multiple myeloma. (McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C) N Engl J Med 2012 May 10;366(19):1770-81 PMID: 22571201 PMCID: PMC3744390 05/11/2012 No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. (Tomblyn M, Chen M, Kukreja M, Aljurf MD, Al Mohareb F, Bolwell BJ, Cahn JY, Carabasi MH, Gale RP, Gress RE, Gupta V, Hale GA, Ljungman P, Maziarz RT, Storek J, Wingard JR, Young JA, Horowitz MM, Ballen KK) Transpl Infect Dis 2012 Oct;14(5):468-78 PMID: 22548788 PMCID: PMC3481161 SCOPUS ID: 2-s2.0-84867636563 05/03/2012 16 CitationsFludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. (Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID, Carter SL, Horowitz MM, Nakamura R, Pulsipher MA, Difronzo NL, Confer DL, Eapen M, Anderlini P) Biol Blood Marrow Transplant 2012 Jul;18(7):1007-11 PMID: 22546497 PMCID: PMC3677744 SCOPUS ID: 2-s2.0-84862131215 05/02/2012 42 CitationsAllogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. (Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W) Biol Blood Marrow Transplant 2012 Sep;18(9):1446-54 PMID: 22449610 PMCID: PMC3499973 SCOPUS ID: 2-s2.0-84865198731 03/28/2012 16 CitationsTwo cases of transfusion-transmitted Anaplasma phagocytophilum. (Annen K, Friedman K, Eshoa C, Horowitz M, Gottschall J, Straus T) Am J Clin Pathol 2012 Apr;137(4):562-5 PMID: 22431531 SCOPUS ID: 2-s2.0-84860590931 03/21/2012 48 CitationsEffect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. (Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Lancet Oncol 2012 Apr;13(4):366-74 PMID: 22340965 PMCID: PMC3813000 SCOPUS ID: 2-s2.0-84859161258 02/22/2012 276 CitationsOutcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. (Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J) Blood 2012 Apr 26;119(17):3908-16 PMID: 22327226 PMCID: PMC3350357 SCOPUS ID: 2-s2.0-84860342455 02/14/2012 209 CitationsOutcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. (Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM) Biol Blood Marrow Transplant 2012 Jun;18(6):861-73 PMID: 22040843 PMCID: PMC3288160 SCOPUS ID: 2-s2.0-84860840686 11/02/2011 52 CitationsRisk factors for acute GVHD and survival after hematopoietic cell transplantation. (Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T) Blood 2012 Jan 05;119(1):296-307 PMID: 22010102 PMCID: PMC3251233 SCOPUS ID: 2-s2.0-84862908566 10/20/2011 521 CitationsPrognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. (Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey A, Szer J, Giralt SA, Maziarz RT, Cortes J, Horowitz MM, Lee SJ) Bone Marrow Transplant 2012 Jun;47(6):810-6 PMID: 21986636 PMCID: PMC3896981 SCOPUS ID: 2-s2.0-84862205894 10/12/2011 76 CitationsEffect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. (Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Garcia-Lopez J, Hattersely G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, Horowitz MM, Gluckman E, Rocha V, Eurocord-European Group for Blood and Marrow Transplantation, Netcord, Center for International Blood and Marrow Transplant Research) Lancet Oncol 2011 Dec;12(13):1214-21 PMID: 21982422 PMCID: PMC3245836 SCOPUS ID: 2-s2.0-82555165881 10/11/2011 167 CitationsEasy-to-read informed consent forms for hematopoietic cell transplantation clinical trials. (Denzen EM, Santibáñez ME, Moore H, Foley A, Gersten ID, Gurgol C, Majhail NS, Spellecy R, Horowitz MM, Murphy EA) Biol Blood Marrow Transplant 2012 Feb;18(2):183-9 PMID: 21806948 PMCID: PMC3242929 SCOPUS ID: 2-s2.0-84855597249 10/05/2011 22 CitationsAutologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. (Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E 3rd, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG, Blood Marrow Transplant Clinical Trials Network (BMT CTN)) Lancet Oncol 2011 Dec;12(13):1195-203 PMID: 21962393 PMCID: PMC3611089 SCOPUS ID: 2-s2.0-82555179157 10/04/2011 248 CitationsRisk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. (Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ) Blood 2011 Oct 20;118(16):4472-9 PMID: 21878671 PMCID: PMC3204914 SCOPUS ID: 2-s2.0-80054832128 09/01/2011 39 CitationsEffect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. (Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JC, Deeg HJ) Blood 2011 Sep 01;118(9):2618-21 PMID: 21677312 PMCID: PMC3167362 SCOPUS ID: 2-s2.0-80052406910 06/17/2011 124 CitationsChronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. (Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MM, Pavletic SZ) Blood 2011 Jun 16;117(24):6714-20 PMID: 21493797 PMCID: PMC3123030 SCOPUS ID: 2-s2.0-79959193801 04/16/2011 115 CitationsImpact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. (Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M) Blood 2011 Jun 23;117(25):6963-70 PMID: 21464372 PMCID: PMC3128486 SCOPUS ID: 2-s2.0-79959496711 04/06/2011 298 CitationsLong-term survival and late deaths after allogeneic hematopoietic cell transplantation. (Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G) J Clin Oncol 2011 Jun 01;29(16):2230-9 PMID: 21464398 PMCID: PMC3107742 SCOPUS ID: 2-s2.0-79957958325 04/06/2011 507 CitationsTrends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. (Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M) Biol Blood Marrow Transplant 2011 Sep;17(9):1352-61 PMID: 21440654 PMCID: PMC3371191 SCOPUS ID: 2-s2.0-79961002454 03/29/2011 15 CitationsAlternative donor transplantation for aplastic anemia. (Eapen M, Horowitz MM) Hematology Am Soc Hematol Educ Program 2010;2010:43-6 PMID: 21239769 SCOPUS ID: 2-s2.0-79955032731 01/18/2011 18 CitationsReview of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and Medicaid Services. (Giralt SA, Horowitz M, Weisdorf D, Cutler C) J Clin Oncol 2011 Feb 10;29(5):566-72 PMID: 21220586 PMCID: PMC4874212 SCOPUS ID: 2-s2.0-79952076075 01/12/2011 28 CitationsGuidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network. (Horwitz EM, Horowitz MM, DiFronzo NL, Kohn DB, Heslop HE, Blood and Marrow Transplant Clinical Trials Network, State of the Science Cell and Gene Therapy Committee) Biol Blood Marrow Transplant 2011 Feb;17(2):192-6 PMID: 21182973 PMCID: PMC3387575 SCOPUS ID: 2-s2.0-79251497333 12/25/2010 1 CitationAutologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. (Tomblyn MR, Ewell M, Bredeson C, Kahl BS, Goodman SA, Horowitz MM, Vose JM, Negrin RS, Laport GG) Biol Blood Marrow Transplant 2011 Jul;17(7):1051-7 PMID: 21073974 PMCID: PMC3114272 SCOPUS ID: 2-s2.0-79958718993 11/16/2010 62 CitationsOptimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. (Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH) Biol Blood Marrow Transplant 2011 Mar;17(3):291-9 PMID: 21034841 PMCID: PMC3053041 SCOPUS ID: 2-s2.0-79551684829 11/03/2010 33 CitationsSecondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. (Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G) Blood 2011 Jan 06;117(1):316-22 PMID: 20926773 PMCID: PMC3037753 SCOPUS ID: 2-s2.0-78650988748 10/12/2010 167 CitationsFactors associated with self-reported physical and mental health after hematopoietic cell transplantation. (Wingard JR, Huang IC, Sobocinski KA, Andrykowski MA, Cella D, Rizzo JD, Brady M, Horowitz MM, Bishop MM) Biol Blood Marrow Transplant 2010 Dec;16(12):1682-92 PMID: 20685400 PMCID: PMC2975785 SCOPUS ID: 2-s2.0-78149407957 08/06/2010 35 CitationsAccess to hematopoietic stem cell transplantation: effect of race and sex. (Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM) Cancer 2010 Jul 15;116(14):3469-76 PMID: 20564154 PMCID: PMC3153958 SCOPUS ID: 2-s2.0-77954889709 06/22/2010 116 CitationsEffect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. (Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE, Center for International Blood and Marrow Transplant Research, Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation), National Cord Blood Program of the New York Blood Center) Lancet Oncol 2010 Jul;11(7):653-60 PMID: 20558104 PMCID: PMC3163510 SCOPUS ID: 2-s2.0-77954031042 06/19/2010 481 CitationsFactors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. (Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS) Bone Marrow Transplant 2011 Jan;46(1):70-6 PMID: 20436518 PMCID: PMC3366187 SCOPUS ID: 2-s2.0-78651378621 05/04/2010 68 CitationsHematopoietic stem cell transplantation: a global perspective. (Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A, Gratwohl M, Frauendorfer K, Niederwieser D, Horowitz M, Kodera Y, Worldwide Network of Blood and Marrow Transplantation) JAMA 2010 Apr 28;303(16):1617-24 PMID: 20424252 PMCID: PMC3219875 SCOPUS ID: 2-s2.0-77951623928 04/29/2010 524 CitationsRelapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. (Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD) J Clin Oncol 2010 Apr 10;28(11):1888-95 PMID: 20212247 PMCID: PMC2860369 SCOPUS ID: 2-s2.0-77951632041 03/10/2010 105 CitationsUnrelated hematopoietic stem cell donors as research subjects. (King RJ, Confer DL, Greinix HT, Halter J, Horowitz M, Schmidt AH, Costeas P, Shaw B, Egeland T, Ethics and Clinical Working Groups of World Marrow Donor Association) Bone Marrow Transplant 2011 Jan;46(1):10-3 PMID: 20190845 SCOPUS ID: 2-s2.0-78650976148 03/02/2010 14 CitationsRe: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure data. (Hurley CK, Oudshoorn M, Setterholm M, Spellman SR, Petersdorf E, Lee SJ, Gooley T, Malkki M, Horowitz MM) Biol Blood Marrow Transplant 2010 Jun;16(6):865-6 PMID: 20172039 SCOPUS ID: 2-s2.0-77952671842 02/23/2010 Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products. (Hurley CK, Foeken L, Horowitz M, Lindberg B, McGregor M, Sacchi N, WMDA Accreditation and Regulatory Committees) Bone Marrow Transplant 2010 May;45(5):819-24 PMID: 20173794 SCOPUS ID: 2-s2.0-77952427875 02/23/2010 15 CitationsResponse to Letter from Demetrios S. Theodoropoulos, MD, DSc. (Gajewski JL, Lill M, Horowitz M, Maziarz RT) Biol Blood Marrow Transplant 2010 Apr;16(4):561-2 PMID: 20139024 SCOPUS ID: 2-s2.0-77649286456 02/09/2010 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini MC, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2010:87-105 PMID: 21696033 SCOPUS ID: 2-s2.0-79960030746 01/01/2010 138 CitationsAllogeneic hematopoietic cell transplant for prolymphocytic leukemia. (Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ, Horowitz MM, Arora M) Biol Blood Marrow Transplant 2010 Apr;16(4):543-7 PMID: 19961946 PMCID: PMC2839005 SCOPUS ID: 2-s2.0-77949271439 12/08/2009 31 CitationsHigh-resolution typing for unrelated donor transplantation: how far do we go? (Horowitz MM) Best Pract Res Clin Haematol 2009 Dec;22(4):537-41 PMID: 19959105 PMCID: PMC2904986 SCOPUS ID: 2-s2.0-71749109588 12/05/2009 18 CitationsBlood and marrow transplant organizations (Keating A, Apperley J, Horowitz M, Horwitz E, Warkentin P, Weisdorf D) Hematopoietic Stem Cell Transplantation in Clinical Practice 2009:513-521 SCOPUS ID: 2-s2.0-84884421130 12/01/2009 Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. (Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang MJ, Horowitz MM, Abhyankar S) Bone Marrow Transplant 2010 Jun;45(6):1068-76 PMID: 19915634 PMCID: PMC3376382 SCOPUS ID: 2-s2.0-77954864138 11/17/2009 41 CitationsDefining the intensity of conditioning regimens: working definitions. (Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M) Biol Blood Marrow Transplant 2009 Dec;15(12):1628-33 PMID: 19896087 PMCID: PMC2861656 SCOPUS ID: 2-s2.0-70350764819 11/10/2009 1325 CitationsChronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. (Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R, European LeukemiaNet) J Clin Oncol 2009 Dec 10;27(35):6041-51 PMID: 19884523 PMCID: PMC4979100 SCOPUS ID: 2-s2.0-73349122639 11/04/2009 1122 CitationsOutcome of transplantation for myelofibrosis. (Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kröger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Arora M) Biol Blood Marrow Transplant 2010 Mar;16(3):358-67 PMID: 19879949 PMCID: PMC2908949 SCOPUS ID: 2-s2.0-75749125700 11/03/2009 221 CitationsSibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. (Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn JY, Cervantes F, Copelan E, Gale R, Gratwohl A, Khoury HJ, McCarthy P, Marks DI, Szer J, Woolfrey A, Cortes-Franco J, Horowitz MM, Arora M, Chronic Leukemia Working Committee) Biol Blood Marrow Transplant 2009 Nov;15(11):1475-8 PMID: 19822308 PMCID: PMC2929002 SCOPUS ID: 2-s2.0-70350619476 10/14/2009 36 CitationsImpending challenges in the hematopoietic stem cell transplantation physician workforce. (Gajewski JL, LeMaistre CF, Silver SM, Lill MC, Selby GB, Horowitz MM, Rizzo JD, Heslop HE, Anasetti C, Maziarz RT) Biol Blood Marrow Transplant 2009 Dec;15(12):1493-501 PMID: 19781658 SCOPUS ID: 2-s2.0-70350475710 09/29/2009 45 CitationsStem cell donation--what advice can be given to the donor? (Pamphilon D, Siddiq S, Brunskill S, Dorée C, Hyde C, Horowitz M, Stanworth S) Br J Haematol 2009 Oct;147(1):71-6 PMID: 19681886 PMCID: PMC3409390 SCOPUS ID: 2-s2.0-70349203764 08/18/2009 10 CitationsDonor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. (Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL) Blood 2009 Sep 24;114(13):2606-16 PMID: 19608747 PMCID: PMC2756121 SCOPUS ID: 2-s2.0-70350513277 07/18/2009 117 CitationsHLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. (Baxter-Lowe LA, Maiers M, Spellman SR, Haagenson MD, Wang T, Fernandez-Vina M, Marsh SG, Horowitz M, Hurley CK) Biol Blood Marrow Transplant 2009 Aug;15(8):971-81 PMID: 19589487 PMCID: PMC2747529 SCOPUS ID: 2-s2.0-67649588922 07/11/2009 23 CitationsAllogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. (Gupta V, Tomblyn M, Pedersen TL, Atkins HL, Battiwalla M, Gress RE, Pollack MS, Storek J, Thompson JC, Tiberghien P, Young JA, Ribaud P, Horowitz MM, Keating A) Biol Blood Marrow Transplant 2009 Jul;15(7):864-71 PMID: 19539219 PMCID: PMC2881828 SCOPUS ID: 2-s2.0-66949130694 06/23/2009 49 CitationsEtanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. (Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE, Blood and Marrow Transplant Clinical Trials Network) Blood 2009 Jul 16;114(3):511-7 PMID: 19443659 PMCID: PMC2713466 SCOPUS ID: 2-s2.0-70149109879 05/16/2009 187 CitationsRapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. (Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):589-96 PMID: 19361751 PMCID: PMC2688780 SCOPUS ID: 2-s2.0-63749091853 04/14/2009 27 CitationsPrior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation. (Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S, Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA) Br J Haematol 2009 Jun;145(6):816-24 PMID: 19344418 PMCID: PMC3355660 SCOPUS ID: 2-s2.0-66749129586 04/07/2009 61 CitationsRisk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. (Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE) Blood 2009 May 14;113(20):4992-5001 PMID: 19264919 PMCID: PMC2686146 SCOPUS ID: 2-s2.0-66549099010 03/07/2009 336 CitationsUses and Growth of Hematopoietic Cell Transplantation (Horowitz MM) Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition 5 March 2009:15-21 SCOPUS ID: 2-s2.0-84890736193 03/05/2009 27 CitationsHLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. (Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK, Selby GB, Antin JH, Kernan NA, Kollman C, Nademanee A, McGlave P, Horowitz MM, Petersdorf EW) J Clin Oncol 2009 Apr 01;27(10):1644-52 PMID: 19224849 PMCID: PMC2668970 SCOPUS ID: 2-s2.0-63749113237 02/20/2009 91 CitationsReduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. (Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B) Biol Blood Marrow Transplant 2009 Mar;15(3):367-9 PMID: 19203728 PMCID: PMC3110087 SCOPUS ID: 2-s2.0-59349093509 02/11/2009 667 CitationsAdverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL) Blood 2009 Apr 09;113(15):3604-11 PMID: 19190248 PMCID: PMC2668845 SCOPUS ID: 2-s2.0-65349145905 02/05/2009 212 CitationsThe graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. (Ringdén O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M) Blood 2009 Mar 26;113(13):3110-8 PMID: 19059878 PMCID: PMC2662650 SCOPUS ID: 2-s2.0-63849276967 12/09/2008 138 CitationsInfluence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). (Lazarus HM, Carreras J, Boudreau C, Loberiza FR Jr, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Miller AM, Pavlovsky S, Schouten HC, van Besien K, Vose JM, Bitran JD, Khouri IF, McCarthy PL, Yu H, Rowlings P, Serna DS, Horowitz MM, Rizzo JD, Center For International Blood & Marrow Transplant Research (CIBMTR)) Biol Blood Marrow Transplant 2008 Dec;14(12):1323-33 PMID: 19041053 PMCID: PMC2638759 SCOPUS ID: 2-s2.0-56749184062 12/02/2008 35 CitationsUnrelated donor hematopoietic cell transplantation: factors associated with a better HLA match. (Dehn J, Arora M, Spellman S, Setterholm M, Horowitz M, Confer D, Weisdorf D) Biol Blood Marrow Transplant 2008 Dec;14(12):1334-40 PMID: 19041054 PMCID: PMC3319684 SCOPUS ID: 2-s2.0-56549129073 12/02/2008 46 CitationsSpecial issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. (Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK, Shamsi T, Othman TB, Sarhan MM, Dennison D, Ibrahim A, Benchekroun S, Chaudhri N, Labar B, Horowitz M, Niederwieser D, Gratwohl A) Bone Marrow Transplant 2009 Jan;43(1):1-12 PMID: 19043456 PMCID: PMC3351791 SCOPUS ID: 2-s2.0-58549083544 12/02/2008 29 CitationsUse of biological assignment in hematopoietic stem cell transplantation clinical trials. (Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N) Clin Trials 2008;5(6):607-16 PMID: 19029209 PMCID: PMC2671015 SCOPUS ID: 2-s2.0-61449562164 11/26/2008 20 CitationsSolid cancers after allogeneic hematopoietic cell transplantation. (Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ) Blood 2009 Jan 29;113(5):1175-83 PMID: 18971419 PMCID: PMC2635083 SCOPUS ID: 2-s2.0-60849115555 10/31/2008 390 CitationsThe role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research. (Horowitz M) Bone Marrow Transplant 2008 Aug;42 Suppl 1:S1-S2 PMID: 18724277 SCOPUS ID: 2-s2.0-50549094738 09/25/2008 58 CitationsSirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. (Cutler C, Stevenson K, Kim HT, Richardson P, Ho VT, Linden E, Revta C, Ebert R, Warren D, Choi S, Koreth J, Armand P, Alyea E, Carter S, Horowitz M, Antin JH, Soiffer R) Blood 2008 Dec 01;112(12):4425-31 PMID: 18776081 PMCID: PMC2597119 SCOPUS ID: 2-s2.0-58149388343 09/09/2008 124 CitationsOutcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. (Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA) Biol Blood Marrow Transplant 2008 Sep;14(9):993-1003 PMID: 18721762 PMCID: PMC3321981 SCOPUS ID: 2-s2.0-49649102973 08/30/2008 75 CitationsHLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. (Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz MM, Oudshoorn M) Biol Blood Marrow Transplant 2008 Sep;14(9):1064-1071 PMID: 18721770 PMCID: PMC2572684 SCOPUS ID: 2-s2.0-49449086957 08/30/2008 36 CitationsImpact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. (Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT) Blood 2008 Oct 15;112(8):3500-7 PMID: 18664621 PMCID: PMC2954751 SCOPUS ID: 2-s2.0-54049146732 07/31/2008 115 CitationsClassification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. (Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J) Biol Blood Marrow Transplant 2008 Jul;14(7):748-58 PMID: 18541193 PMCID: PMC2668157 SCOPUS ID: 2-s2.0-44649167561 06/11/2008 182 CitationsOn the probability of using cord blood. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Jun;14(6):724-5 PMID: 18489999 SCOPUS ID: 2-s2.0-43649090840 05/21/2008 4 CitationsDonor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population. (Levine JE, Barrett AJ, Zhang MJ, Arora M, Pulsipher MA, Bunin N, Fort J, Loberiza F, Porter D, Giralt S, Drobyski W, Wang D, Pavletic S, Ringden O, Horowitz MM, Collins R Jr) Bone Marrow Transplant 2008 Aug;42(3):201-5 PMID: 18490913 SCOPUS ID: 2-s2.0-50049106424 05/21/2008 41 CitationsUse of cost-effectiveness analysis to determine inventory size for a national cord blood bank. (Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM) Med Decis Making 2008;28(2):243-53 PMID: 18349441 SCOPUS ID: 2-s2.0-41149179076 03/20/2008 34 CitationsLifetime probabilities of hematopoietic stem cell transplantation in the U.S. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Mar;14(3):316-22 PMID: 18275898 PMCID: PMC2531159 SCOPUS ID: 2-s2.0-38949210240 02/16/2008 50 CitationsHLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A, CIBMTR Acute Leukemia Working Committee) Biol Blood Marrow Transplant 2008 Feb;14(2):187-96 PMID: 18215779 PMCID: PMC2531160 SCOPUS ID: 2-s2.0-38349185874 01/25/2008 45 CitationsLong-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. (Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR Jr, Giralt S, Horowitz MM, Weisdorf DJ) Bone Marrow Transplant 2008 Apr;41(7):635-42 PMID: 18084335 PMCID: PMC2587442 SCOPUS ID: 2-s2.0-42149177725 12/18/2007 46 CitationsPeripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. (Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C) Biol Blood Marrow Transplant 2007 Dec;13(12):1461-8 PMID: 18022576 PMCID: PMC2267869 SCOPUS ID: 2-s2.0-36048969811 11/21/2007 157 CitationsBlood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. (Ferrara JL, Anasetti C, Stadtmauer E, Antin J, Wingard J, Lee S, Levine J, Schultz K, Appelbaum F, Negrin R, Giralt S, Bredeson C, Heslop H, Horowitz M) Biol Blood Marrow Transplant 2007 Nov;13(11):1268-85 PMID: 17950914 SCOPUS ID: 2-s2.0-35348912524 10/24/2007 29 CitationsHigh-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. (Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C) Blood 2007 Dec 15;110(13):4576-83 PMID: 17785583 SCOPUS ID: 2-s2.0-37349118061 09/06/2007 1061 CitationsThe importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. (Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringdén O, Marsh SG, Petersdorf EW) Blood 2007 Dec 15;110(13):4560-6 PMID: 17726164 SCOPUS ID: 2-s2.0-38349017549 08/30/2007 158 CitationsMapping MHC-resident transplantation determinants. (Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, Cornelissen JJ, Dormoy A, Dubois V, Gagne K, Gluckman E, Haagenson MD, Oudshoorn M, Spellman S, Petersdorf EW, International Histocompatibility Working Group in Transplantation) Biol Blood Marrow Transplant 2007 Aug;13(8):986-95 PMID: 17640603 PMCID: PMC3182140 SCOPUS ID: 2-s2.0-34447302894 07/21/2007 16 CitationsOutcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. (Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE) Lancet 2007 Jun 09;369(9577):1947-54 PMID: 17560447 SCOPUS ID: 2-s2.0-34249899377 06/15/2007 678 CitationsImpact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. (Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL, Sobocinski KA, Horowitz MM, Chronic Leukemia Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):461-7 PMID: 17459051 SCOPUS ID: 2-s2.0-34247863611 04/27/2007 67 CitationsClinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. (Petersdorf EW, Gooley T, Malkki M, Horowitz M, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Tissue Antigens 2007 Apr;69 Suppl 1:25-30 PMID: 17445158 SCOPUS ID: 2-s2.0-34247259667 04/21/2007 58 CitationsImmune response gene polymorphisms in unrelated donor hematopoietic cell transplantation. (Malkki M, Gooley T, Dubois V, Horowitz M, Petersdorf EW) Tissue Antigens 2007 Apr;69 Suppl 1:50-3 PMID: 17445163 SCOPUS ID: 2-s2.0-34247258573 04/21/2007 6 CitationsMHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation. (Malkki M, Gooley T, Horowitz M, Petersdorf EW, IHWG HCT Component) Tissue Antigens 2007 Apr;69 Suppl 1:46-9 PMID: 17445162 SCOPUS ID: 2-s2.0-34247188707 04/21/2007 6 Citations14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantation. (Petersdorf E, Bardy P, Cambon-Thomsen A, Goulmy E, Hansen J, Schwarer A, Velardi A, IHWG HCT) Tissue Antigens 2007 Apr;69 Suppl 1:17-24 PMID: 17445157 SCOPUS ID: 2-s2.0-34247184314 04/21/2007 4 CitationsLate effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. (Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR) J Clin Oncol 2007 Apr 10;25(11):1403-11 PMID: 17416860 SCOPUS ID: 2-s2.0-34248166981 04/10/2007 168 CitationsMissing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. (Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ) Blood 2007 Jun 01;109(11):5058-61 PMID: 17317850 PMCID: PMC1885526 SCOPUS ID: 2-s2.0-34247581578 02/24/2007 251 CitationsBlood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions. (Weisdorf D, Carter S, Confer D, Ferrara J, Horowitz M) Biol Blood Marrow Transplant 2007 Mar;13(3):257-62; discussion 255-6 PMID: 17317578 SCOPUS ID: 2-s2.0-33847023872 02/24/2007 15 CitationsBone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. (Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM) Blood 2007 May 15;109(10):4582-5 PMID: 17272503 PMCID: PMC1885491 SCOPUS ID: 2-s2.0-34248376573 02/03/2007 150 CitationsLong-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation) Blood 2006 Dec 15;108(13):4288-90 PMID: 16946302 PMCID: PMC1895450 SCOPUS ID: 2-s2.0-33845478320 09/02/2006 146 CitationsImpact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. (Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL) Biol Blood Marrow Transplant 2006 Jul;12(7):758-69 PMID: 16785065 SCOPUS ID: 2-s2.0-33745166296 06/21/2006 98 CitationsEvolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. (Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R, European LeukemiaNet) Blood 2006 Sep 15;108(6):1809-20 PMID: 16709930 SCOPUS ID: 2-s2.0-33747154547 05/20/2006 1120 CitationsA comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. (Marks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, Trigg ME, Zhang MJ, Horowitz MM) Biol Blood Marrow Transplant 2006 Apr;12(4):438-53 PMID: 16545728 SCOPUS ID: 2-s2.0-33644917778 03/21/2006 157 CitationsBone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. (Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C) Bone Marrow Transplant 2006 Apr;37(7):641-9 PMID: 16489361 SCOPUS ID: 2-s2.0-33645240407 02/21/2006 100 CitationsAutotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. (Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, Zhang MJ, Horowitz MM) Br J Haematol 2006 Mar;132(6):755-69 PMID: 16487177 SCOPUS ID: 2-s2.0-33644900481 02/21/2006 55 CitationsPretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. (Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2006 Feb;12(2):204-16 PMID: 16443518 SCOPUS ID: 2-s2.0-31344460389 01/31/2006 24 CitationsComparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. (Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE) J Clin Oncol 2006 Jan 01;24(1):145-51 PMID: 16382124 SCOPUS ID: 2-s2.0-33644834712 12/31/2005 77 CitationsABO blood group barrier in allogeneic bone marrow transplantation revisited. (Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ, GVHD Working Committee of Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2005 Dec;11(12):1006-13 PMID: 16338623 SCOPUS ID: 2-s2.0-28744440859 12/13/2005 118 CitationsEvaluation of hematopoietic stem cell donors. (Horowitz MM, Confer DL) Hematology Am Soc Hematol Educ Program 2005:469-75 PMID: 16304422 SCOPUS ID: 2-s2.0-33750569562 11/24/2005 67 Citations131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. (Pagel JM, Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L, Carreras J, Horowitz MM, Press OW, Gopal AK, Martin PJ, Bernstein ID, Matthews DC) Blood 2006 Mar 01;107(5):2184-91 PMID: 16254140 PMCID: PMC1895719 SCOPUS ID: 2-s2.0-33344454377 10/29/2005 141 CitationsImpact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. (Khoury HJ, Loberiza FR Jr, Ringdén O, Barrett AJ, Bolwell BJ, Cahn JY, Champlin RE, Gale RP, Hale GA, Urbano-Ispizua A, Martino R, McCarthy PL, Tiberghien P, Verdonck LF, Horowitz MM) Blood 2006 Feb 15;107(4):1712-6 PMID: 16239431 PMCID: PMC1895414 SCOPUS ID: 2-s2.0-32644451371 10/22/2005 73 CitationsOutcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. (Baker KS, Loberiza FR Jr, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ) J Clin Oncol 2005 Oct 01;23(28):7032-42 PMID: 16145067 SCOPUS ID: 2-s2.0-27244459165 09/08/2005 49 CitationsBlood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. (Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S) Biol Blood Marrow Transplant 2005 Aug;11(8):571-5 PMID: 16041306 SCOPUS ID: 2-s2.0-22344434696 07/26/2005 368 CitationsRisk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. (Santo Tomas LH, Loberiza FR Jr, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM) Chest 2005 Jul;128(1):153-61 PMID: 16002929 SCOPUS ID: 2-s2.0-22244447765 07/09/2005 144 CitationsProspective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. (Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G, Société Française de Greffe de Moëlle et Thérapie Cellulaire, Dana Farber Cancer Institute, International Bone Marrow Transplant Registry) Blood 2005 Aug 15;106(4):1495-500 PMID: 15878974 PMCID: PMC1895210 SCOPUS ID: 2-s2.0-23744458895 05/10/2005 166 CitationsImmune therapy of chronic myelogenous leukemia. (Gale RP, Horowitz MM, Talpaz M, Scheinberg DA, Molldrem J, Li Z, Baccarani M, Goldman JM, Tura S) Leuk Res 2005 May;29(5):583-6 PMID: 15755511 SCOPUS ID: 2-s2.0-14744273103 03/10/2005 1 CitationImproved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. (Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B) Blood 2005 Jun 15;105(12):4878-84 PMID: 15731175 PMCID: PMC1894998 SCOPUS ID: 2-s2.0-20444394742 02/26/2005 420 CitationsImpact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. (Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ) Blood 2005 May 15;105(10):3802-11 PMID: 15687239 PMCID: PMC1895092 SCOPUS ID: 2-s2.0-20844439888 02/03/2005 265 CitationsLong-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. (Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR) J Clin Oncol 2005 Jan 20;23(3):599-608 PMID: 15659507 SCOPUS ID: 2-s2.0-20044367440 01/22/2005 262 CitationsAssociation of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. (Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD) Blood 2005 Apr 01;105(7):2979-87 PMID: 15598815 SCOPUS ID: 2-s2.0-20144389335 12/16/2004 77 CitationsOutcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM) N Engl J Med 2004 Nov 25;351(22):2265-75 PMID: 15564543 SCOPUS ID: 2-s2.0-9244256765 11/27/2004 954 CitationsHigher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. (Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringdén O, Wagner JE) J Clin Oncol 2004 Dec 15;22(24):4872-80 PMID: 15520055 SCOPUS ID: 2-s2.0-16644379996 11/03/2004 221 CitationsComparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. (Oh H, Loberiza FR Jr, Zhang MJ, Ringdén O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey J, Kolb HJ, Litzow MR, McCarthy PL, Neudorf SM, Serna DS, Socié G, Tiberghien P, Barrett AJ) Blood 2005 Feb 15;105(4):1408-16 PMID: 15486071 SCOPUS ID: 2-s2.0-13544250493 10/16/2004 133 CitationsAutologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH Jr, Sandler ES, Yeager AM, Edwards JR, Horowitz MM) J Clin Oncol 2004 Sep 15;22(18):3798-804 PMID: 15365077 SCOPUS ID: 2-s2.0-4644343739 09/15/2004 17 CitationsSecond transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M) Bone Marrow Transplant 2004 Oct;34(8):721-7 PMID: 15322568 SCOPUS ID: 2-s2.0-6444220659 08/24/2004 199 CitationsMyeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. (Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K, Lymphoma Working Committee of the International Bone Marrow Transplant Registry) Blood 2004 Dec 01;104(12):3797-803 PMID: 15280203 SCOPUS ID: 2-s2.0-9444272217 07/29/2004 103 CitationsPhysicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation. (Lee SJ, Joffe S, Kim HT, Socie G, Gilman AL, Wingard JR, Horowitz MM, Cella D, Syrjala KL) Blood 2004 Oct 01;104(7):2194-200 PMID: 15198954 SCOPUS ID: 2-s2.0-4644235230 06/17/2004 61 CitationsImpact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. (Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E, Weisdorf D) Blood 2004 Oct 01;104(7):1923-30 PMID: 15191952 SCOPUS ID: 2-s2.0-4644359708 06/12/2004 602 CitationsValidation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants. (Passweg JR, Walker I, Sobocinski KA, Klein JP, Horowitz MM, Giralt SA, Chronic Leukemia Study Writing Committee of the International Bone Marrow Transplant Registry) Br J Haematol 2004 Jun;125(5):613-20 PMID: 15147377 SCOPUS ID: 2-s2.0-2942511357 05/19/2004 81 CitationsA decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. (Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM) Blood 2004 Jul 15;104(2):579-85 PMID: 15039286 SCOPUS ID: 2-s2.0-3142580475 03/25/2004 580 CitationsAutologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. (Vose JM, Rizzo DJ, Tao-Wu J, Armitage JO, Bashey A, Burns LJ, Christiansen NP, Freytes CO, Gale RP, Gibson J, Giralt SA, Herzig RH, Lemaistre CF, McCarthy PL Jr, Nimer SD, Petersen FB, Schenkein DP, Wiernik PH, Wiley JM, Loberiza FR, Lazarus HM, van Biesen K, Horowitz MM) Biol Blood Marrow Transplant 2004 Feb;10(2):116-27 PMID: 14750077 SCOPUS ID: 2-s2.0-0742323747 01/30/2004 47 CitationsHigh dose therapy with autologous hematopoietic stem cell transplantation (HSCT) for patients with primary systemic amyloidosis (AL): An ABMTR study (Vesole DH, Pérez W, Reece D, Akasheh M, Horowitz M, Bredeson C) Amyloid and Amyloidosis 1 January 2004:164-166 SCOPUS ID: 2-s2.0-85057654643 01/01/2004 Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. (Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, Dipersio JF) Biol Blood Marrow Transplant 2003 Nov;9(11):714-21 PMID: 14652855 SCOPUS ID: 2-s2.0-9144224186 12/04/2003 24 CitationsTrends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. (Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr) J Clin Oncol 2003 Oct 15;21(20):3754-60 PMID: 14551294 SCOPUS ID: 2-s2.0-0142023889 10/11/2003 72 CitationsSyngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation) J Clin Oncol 2003 Oct 15;21(20):3744-53 PMID: 12963703 SCOPUS ID: 2-s2.0-0142023893 09/10/2003 136 CitationsComparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. (van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM) Blood 2003 Nov 15;102(10):3521-9 PMID: 12893748 SCOPUS ID: 2-s2.0-0242411675 08/02/2003 315 CitationsSyngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. (Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH) Bone Marrow Transplant 2003 Jul;32(2):151-5 PMID: 12838279 SCOPUS ID: 2-s2.0-10744226696 07/03/2003 4 CitationsDecreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. (Ringdén O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS, Gale RP, Hale GA, Litzow MR, Martino R, Russell JA, Tiberghien P, Urbano-Ispizua A, Horowitz MM) Br J Haematol 2003 Jun;121(6):874-85 PMID: 12786798 SCOPUS ID: 2-s2.0-0037930786 06/06/2003 76 CitationsPerformance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. (Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB) Blood 2003 Aug 01;102(3):802-9 PMID: 12714524 SCOPUS ID: 2-s2.0-0042243679 04/26/2003 125 CitationsTransplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? (Loberiza FR Jr, Serna DS, Horowitz MM, Rizzo JD) Bone Marrow Transplant 2003 Mar;31(6):417-21 PMID: 12665834 SCOPUS ID: 2-s2.0-0037366808 04/01/2003 31 CitationsOutcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. (Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N) Br J Haematol 2003 Mar;120(5):793-800 PMID: 12614212 SCOPUS ID: 2-s2.0-0037336639 03/05/2003 145 CitationsAccess to stem cell transplantation: do women fare as well as men? (Mehta P, Pollock BH, Nugent M, Horowitz M, Wingard JR) Am J Hematol 2003 Feb;72(2):99-102 PMID: 12555212 SCOPUS ID: 2-s2.0-12244268630 01/30/2003 16 CitationsComparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. (Litzow MR, Pérez WS, Klein JP, Bolwell BJ, Camitta B, Copelan EA, Gale RP, Giralt SA, Keating A, Lazarus HM, Marks DI, McCarthy PL, Miller CB, Milone G, Prentice HG, Russell JA, Schultz KR, Trigg ME, Weisdorf DJ, Horowitz MM) Br J Haematol 2002 Dec;119(4):1115-24 PMID: 12472596 SCOPUS ID: 2-s2.0-0036456695 12/11/2002 90 CitationsA comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. (Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ, Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry) Blood 2003 Apr 01;101(7):2476-82 PMID: 12456505 SCOPUS ID: 2-s2.0-0038446692 11/29/2002 133 CitationsThe international bone marrow transplant registry. (Goldman JM, Horowitz MM) Int J Hematol 2002 Aug;76 Suppl 1:393-7 PMID: 12430889 SCOPUS ID: 2-s2.0-0038164198 11/15/2002 66 CitationsMyelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. (Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ) Blood 2003 Mar 01;101(5):2015-23 PMID: 12393427 SCOPUS ID: 2-s2.0-0037370887 10/24/2002 180 CitationsConference synopsis: hematopoietic stem cell therapy in autoimmune diseases, October 2001. Biol Blood Marrow Transplant 2002;8(8):407-11 PMID: 12234165 SCOPUS ID: 2-s2.0-0036374475 09/18/2002 4 CitationsBone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. (Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM) Blood 2002 Sep 15;100(6):1997-2004 PMID: 12200358 SCOPUS ID: 2-s2.0-0037105374 08/30/2002 246 CitationsDefining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. (Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T, Fuchs HJ, Haskins MN, Horowitz MM, Martin PJ, McGuire DB, Mullane K, Oster G) Cancer Invest 2002;20(5-6):793-800 PMID: 12197238 SCOPUS ID: 2-s2.0-0036044122 08/29/2002 51 CitationsReporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation. (Martin PJ, Antin JH, Weisdorf DJ, Paton V, Horowitz MM) Biol Blood Marrow Transplant 2002;8(6):295-302 PMID: 12108915 SCOPUS ID: 2-s2.0-0036063859 07/11/2002 8 CitationsSeverity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. (Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM) Blood 2002 Jul 15;100(2):406-14 PMID: 12091329 SCOPUS ID: 2-s2.0-0037100551 07/02/2002 461 CitationsAutologous stem cell transplantation for small cell lung cancer. (Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM) Biol Blood Marrow Transplant 2002;8(5):273-80 PMID: 12064365 SCOPUS ID: 2-s2.0-0036276301 06/18/2002 14 CitationsAutologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. (Weisdorf D, Bishop M, Dharan B, Bolwell B, Cahn JY, Cairo M, Giralt S, Klein J, Lazarus H, Litzow M, Marks D, McCarthy P, Miller C, Milone G, Russell J, Schultz KR, Sierra J, Wiernik P, Keating A, Loberiza F, Kollman C, Horowitz M) Biol Blood Marrow Transplant 2002;8(4):213-20 PMID: 12014810 SCOPUS ID: 2-s2.0-0035999678 05/17/2002 49 CitationsAssociation of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. (Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ) J Clin Oncol 2002 Apr 15;20(8):2118-26 PMID: 11956273 SCOPUS ID: 2-s2.0-0037089593 04/17/2002 183 CitationsEffect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. (van Rood JJ, Loberiza FR Jr, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, Champlin RE, Gale RP, Ringdén O, Hows JM, Horowitz MH) Blood 2002 Mar 01;99(5):1572-7 PMID: 11861270 SCOPUS ID: 2-s2.0-0036493859 02/28/2002 240 CitationsA survey of diagnosis, management, and grading of chronic GVHD. (Lee SJ, Vogelsang G, Gilman A, Weisdorf DJ, Pavletic S, Antin JH, Horowitz MM, Akpek G, Flowers ME, Couriel D, Martin PJ) Biol Blood Marrow Transplant 2002;8(1):32-9 PMID: 11846354 SCOPUS ID: 2-s2.0-0036169694 02/16/2002 88 CitationsHigh-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. (Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM) J Clin Oncol 2002 Feb 01;20(3):743-50 PMID: 11821456 SCOPUS ID: 2-s2.0-0036468810 02/01/2002 58 CitationsProspective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. (Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH Jr) J Clin Oncol 2002 Jan 15;20(2):405-12 PMID: 11786567 SCOPUS ID: 2-s2.0-0037080121 01/12/2002 238 CitationsAnalysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. (Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR) Biol Blood Marrow Transplant 2001;7(11):620-30 PMID: 11760150 SCOPUS ID: 2-s2.0-0034747266 01/05/2002 57 CitationsThe effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. (Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM) Blood 2001 Dec 01;98(12):3205-11 PMID: 11719355 SCOPUS ID: 2-s2.0-0035760886 11/24/2001 24 CitationsThe effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. (Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM) Exp Hematol 2001 Nov;29(11):1336-46 PMID: 11698130 11/08/2001 Documenting the case for stem cell transplantation: the role of evidence-based reviews and implications for future research. Statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation (ASBMT). (Jones MR, Horowitz M, Wall D, Wingard JR, Wolff S, Steering Committee for Evidence-Based reviews of the American Society for Blood and Marrow Transplantation (ABSMT)) Biol Blood Marrow Transplant 2001;7(6):306-7 PMID: 11464974 SCOPUS ID: 2-s2.0-0034912962 07/24/2001 1 CitationMulti-state models and outcome prediction in bone marrow transplantation. (Keiding N, Klein JP, Horowitz MM) Stat Med 2001 Jun 30;20(12):1871-85 PMID: 11406847 SCOPUS ID: 2-s2.0-0035973278 06/15/2001 73 CitationsTransplant registries: guiding clinical decisions and improving outcomes. (Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML) Oncology (Williston Park) 2001 May;15(5):649-59; discussion 663-4, 666 PMID: 11396358 SCOPUS ID: 2-s2.0-0035351024 06/09/2001 29 CitationsPeripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. (Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM, IBMTR Statistical Center of the International Bone Marrow Transplant Registry, Medical College of Wisconcin, Milwaukee, WI, USA, EBMT, Kiel, Germany) Bone Marrow Transplant 2001 Apr;27(7):689-92 PMID: 11360107 SCOPUS ID: 2-s2.0-0035037982 05/22/2001 118 CitationsAutotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). (Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM) Bone Marrow Transplant 2001 Feb;27(4):387-96 PMID: 11313668 SCOPUS ID: 2-s2.0-17744384690 04/21/2001 110 CitationsOral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. (Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M) J Clin Oncol 2001 Apr 15;19(8):2201-5 PMID: 11304772 SCOPUS ID: 2-s2.0-0035870833 04/17/2001 544 CitationsImpact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. (Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringdén O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM) Blood 2001 Mar 15;97(6):1598-603 PMID: 11238097 SCOPUS ID: 2-s2.0-0035869537 03/10/2001 249 CitationsAutologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO, Pavlovsky S, Keating A, Yanes B, van Besien K, Armitage JO, Horowitz MM, Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee) J Clin Oncol 2001 Jan 15;19(2):406-13 PMID: 11208832 SCOPUS ID: 2-s2.0-0035863505 02/24/2001 190 CitationsDonor leukocyte infusions for multiple myeloma. (Salama M, Nevill T, Marcellus D, Parker P, Johnson M, Kirk A, Porter D, Giralt S, Levine JE, Drobyski W, Barrett AJ, Horowitz M, Collins RH) Bone Marrow Transplant 2000 Dec;26(11):1179-84 PMID: 11149728 SCOPUS ID: 2-s2.0-0033665539 01/10/2001 161 CitationsASBMT policy statement regarding the methodology of evidence-based reviews in evaluating the role of blood and marrow transplantation in the treatment of selected diseases. American Society for Blood and Marrow Transplantation. (Jones R, Horowitz M, Wall D, Wingard J, Wolff S, McCarthy P, Hahn T, American Society for Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2000;6(5):524-5 PMID: 11063382 SCOPUS ID: 2-s2.0-0034576897 11/04/2000 7 CitationsDonor leukocyte infusions in acute lymphocytic leukemia. (Collins RH Jr, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W, Barrett J, Johnson M, Kirk A, Horowitz M, Parker P) Bone Marrow Transplant 2000 Sep;26(5):511-6 PMID: 11019840 SCOPUS ID: 2-s2.0-0033832579 10/06/2000 212 CitationsHigh-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. (Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM) Ann Intern Med 2000 Oct 03;133(7):504-15 PMID: 11015163 SCOPUS ID: 2-s2.0-0034601768 10/03/2000 48 CitationsEffect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. (Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM) Blood 2000 Aug 15;96(4):1254-8 PMID: 10942365 SCOPUS ID: 2-s2.0-0034663034 08/15/2000 107 CitationsGraft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. (Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E) N Engl J Med 2000 Jun 22;342(25):1846-54 PMID: 10861319 SCOPUS ID: 2-s2.0-0034702284 06/22/2000 770 CitationsT-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. (Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O'Reilly RJ, Ringdén O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Blood 2000 Jun 15;95(12):3996-4003 PMID: 10845940 SCOPUS ID: 2-s2.0-18844467941 06/14/2000 141 CitationsBlood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). (Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A) Blood 2000 Jun 15;95(12):3702-9 PMID: 10845900 SCOPUS ID: 2-s2.0-0344925935 06/14/2000 462 CitationsEffect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. (Barrett AJ, Ringdén O, Zhang MJ, Bashey A, Cahn JY, Cairo MS, Gale RP, Gratwohl A, Locatelli F, Martino R, Schultz KR, Tiberghien P) Blood 2000 Jun 01;95(11):3323-7 PMID: 10828011 SCOPUS ID: 2-s2.0-0034210638 05/29/2000 75 CitationsCurrent status of allogeneic bone marrow transplantation in acquired aplastic anemia. (Horowitz MM) Semin Hematol 2000 Jan;37(1):30-42 PMID: 10676909 SCOPUS ID: 2-s2.0-0033960663 02/17/2000 97 CitationsNew malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. (Socié G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, Sullivan KM, Rowlings PA, Kingma DW, Banks PM, Travis WD, Witherspoon RP, Sanders J, Jaffe ES, Horowitz MM) J Clin Oncol 2000 Jan;18(2):348-57 PMID: 10637249 SCOPUS ID: 2-s2.0-0033958782 01/19/2000 287 CitationsComparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, Camitta BM, Gale RP, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, Milone GA, Neudorf S, Perez WS, Powles RL, Prentice HG, Schiller G, Socié G, Vowels M, Wiley J, Yeager A, Horowitz MM) J Clin Oncol 2000 Jan;18(2):340-7 PMID: 10637248 SCOPUS ID: 2-s2.0-0033955223 01/19/2000 205 CitationsEffect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry. (Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM) Blood 2000 Jan 15;95(2):410-5 PMID: 10627443 SCOPUS ID: 2-s2.0-12944310971 01/11/2000 28 CitationsLong-term survival after bone marrow transplantation. (Oki Y, Kami M, Muto Y) N Engl J Med 1999 Oct 28;341(18):1394; author reply 1395 PMID: 10577087 SCOPUS ID: 2-s2.0-0033613345 11/30/1999 Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM) JAMA 1999 Oct 13;282(14):1335-43 PMID: 10527180 SCOPUS ID: 2-s2.0-0033552263 10/20/1999 66 CitationsIncreased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. (Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socié G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM) J Clin Oncol 1999 Oct;17(10):3122-7 PMID: 10506608 SCOPUS ID: 2-s2.0-0032885819 10/03/1999 83 CitationsRisk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. (Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ) Blood 1999 Oct 01;94(7):2208-16 PMID: 10498590 SCOPUS ID: 2-s2.0-0033214901 09/25/1999 588 CitationsCorrection of primary immunodeficiencies with bone marrow transplantation from unrelated donors (Filipovich AH, Fasth A, Portal F, Landais P, Pelz C, Murphy S, Sobocinski K, Horowitz M, King R, Hegland J, Kollman C, Ireland M) Cancer Research Therapy and Control 1999;9(1-2):67-71 SCOPUS ID: 2-s2.0-0032856588 09/07/1999 Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1999 Sep;23(9):817-26 PMID: 10475621 SCOPUS ID: 2-s2.0-0032789247 09/04/1999 8 CitationsAutotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman K) Bone Marrow Transplant 1999 Aug;24(4):365-8 PMID: 10467324 SCOPUS ID: 2-s2.0-0032804995 09/01/1999 9 CitationsDelphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1999 Aug;23(8):709-18 PMID: 10456668 SCOPUS ID: 2-s2.0-0344690184 08/24/1999 13 CitationsModelling covariate adjusted mortality relative to a standard population. (Andersen PK, Horowitz MM, Klein JP, Socie G, Stone JV, Zhang MJ) Stat Med 1999 Jun 30;18(12):1529-40 PMID: 10398290 SCOPUS ID: 2-s2.0-0033618089 07/09/1999 3 CitationsTacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. (Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR) Biol Blood Marrow Transplant 1999;5(3):180-6 PMID: 10392964 SCOPUS ID: 2-s2.0-0032601818 07/07/1999 28 CitationsLong-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. (Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP) N Engl J Med 1999 Jul 01;341(1):14-21 PMID: 10387937 SCOPUS ID: 2-s2.0-0033168009 07/01/1999 624 CitationsAutotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM) J Clin Oncol 1999 Feb;17(2):534-45 PMID: 10080597 SCOPUS ID: 2-s2.0-0033008436 03/18/1999 180 CitationsBone marrow transplants for paroxysmal nocturnal haemoglobinuria. (Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA, Passweg JR, Nugent ML, Luzzatto L, Horowitz MM, Gordon-Smith EC) Br J Haematol 1999 Feb;104(2):392-6 PMID: 10050724 SCOPUS ID: 2-s2.0-0032936695 03/02/1999 112 CitationsImproving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. (Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM, Barrett AJ, Waldmann H) Blood 1998 Dec 15;92(12):4581-90 PMID: 9845524 SCOPUS ID: 2-s2.0-0032535279 12/09/1998 173 CitationsMethods for assessment of graft-versus-host disease. (Martin PJ, Schoch G, Gooley T, Anasetti C, Deeg HJ, Nash R, Sanders J, Storb R, Appelbaum F) Blood 1998 Nov 01;92(9):3479-81 PMID: 9787194 SCOPUS ID: 2-s2.0-0032211184 10/27/1998 12 CitationsDelphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1998 Nov;22(11):973-81 PMID: 9783798 SCOPUS ID: 2-s2.0-0031667502 10/23/1998 14 CitationsInitial therapy for chronic myelogenous leukemia: playing the odds. (Lee SJ, Anasetti C, Horowitz MM, Antin JH) J Clin Oncol 1998 Sep;16(9):2897-903 PMID: 9738555 SCOPUS ID: 2-s2.0-0031671093 09/17/1998 29 CitationsChemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission. (Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, Ohno R, Rowlings PA, Sobocinski KA, Tanimoto M, Tomonaga M, Weisdorf DJ, Horowitz MM) Bone Marrow Transplant 1998 Aug;22(3):253-7 PMID: 9720738 SCOPUS ID: 2-s2.0-0031853347 08/28/1998 42 CitationsAllogeneic bone marrow transplantation for low-grade lymphoma. (van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy PL Jr, Raemaekers JM, Reiffers J, Phillips GL, Schattenberg AV, Verdonck LF, Vose JM, Horowitz MM) Blood 1998 Sep 01;92(5):1832-6 PMID: 9716615 SCOPUS ID: 2-s2.0-0032170122 08/26/1998 240 CitationsInfluence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. (Passweg JR, Rowlings PA, Atkinson KA, Barrett AJ, Gale RP, Gratwohl A, Jacobsen N, Klein JP, Ljungman P, Russell JA, Schaefer UW, Sobocinski KA, Vossen JM, Zhang MJ, Horowitz MM) Bone Marrow Transplant 1998 Jun;21(12):1231-8 PMID: 9674857 SCOPUS ID: 2-s2.0-0031849022 07/23/1998 120 CitationsUnrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. (Sullivan KM, Anasetti C, Horowitz M, Rowlings PA, Petersdorf EW, Martin PJ, Clift RA, Walters MC, Gooley T, Sierra J, Anderson JE, Bjerke J, Siadak M, Flowers ME, Nash RA, Sanders JE, Appelbaum FR, Storb R, Hansen JA) Ann N Y Acad Sci 1998 Jun 30;850:312-24 PMID: 9668553 SCOPUS ID: 2-s2.0-0031825816 07/21/1998 22 CitationsT cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. (Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski WR, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D) Bone Marrow Transplant 1998 May;21(9):893-9 PMID: 9613781 SCOPUS ID: 2-s2.0-0031894170 06/05/1998 48 CitationsEconomic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know? (Waters TM, Bennett CL, Pajeau TS, Sobocinski KA, Klein JP, Rowlings PA, Horowitz MM) Bone Marrow Transplant 1998 Apr;21(7):641-50 PMID: 9578302 SCOPUS ID: 2-s2.0-0031895116 05/13/1998 43 CitationsRelated donor bone marrow transplantation for chronic myelogenous leukemia. (Passweg JR, Rowlings PA, Horowitz MM) Hematol Oncol Clin North Am 1998 Feb;12(1):81-92 PMID: 9523226 SCOPUS ID: 2-s2.0-0031910352 04/02/1998 8 CitationsSurvival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. (Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM) Blood 1998 Mar 01;91(5):1810-9 PMID: 9473250 SCOPUS ID: 2-s2.0-6844259874 03/21/1998 97 CitationsSafeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. (Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM) Biol Blood Marrow Transplant 1997 Dec;3(6):331-40 PMID: 9502301 SCOPUS ID: 2-s2.0-0031310563 03/21/1998 19 CitationsGraft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. (Passweg JR, Tiberghien P, Cahn JY, Vowels MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah N, Klein JP, Marks DI, Ramsay NK, Rowlings PA, Weisdorf DJ, Zhang MJ, Barrett AJ) Bone Marrow Transplant 1998 Jan;21(2):153-8 PMID: 9489632 SCOPUS ID: 2-s2.0-17744419349 03/07/1998 107 CitationsLong-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. (Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE) Bone Marrow Transplant 1997 Dec;20(12):1069-74 PMID: 9466280 SCOPUS ID: 2-s2.0-0031437525 02/18/1998 100 CitationsAdoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. (Link CJ Jr, Burt RK, Traynor AE, Drobyski WR, Seregina T, Levy JP, Gordon L, Rosen ST, Burns WH, Camitta B, Casper J, Horowitz M, Juckett M, Lawton C, Margolis D, Pietryga D, Rowlings P, Taylor C, Furtado M, Stefka J, Gupta-Burt S, Kaiser H, Vesole DH) Hum Gene Ther 1998 Jan 01;9(1):115-34 PMID: 9458247 SCOPUS ID: 2-s2.0-0031975258 02/11/1998 37 CitationsUnrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. (Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH) Ann Intern Med 1997 Dec 15;127(12):1080-8 PMID: 9412310 SCOPUS ID: 2-s2.0-14444276989 12/31/1997 64 CitationsSurvival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. (Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM) Br J Haematol 1997 Oct;99(1):23-9 PMID: 9359497 SCOPUS ID: 2-s2.0-9844245127 11/14/1997 6 CitationsAn update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. (Horowitz MM, Rowlings PA) Curr Opin Hematol 1997 Nov;4(6):395-400 PMID: 9358995 SCOPUS ID: 2-s2.0-0030734536 11/14/1997 65 CitationsAllogeneic blood stem cell transplantation: considerations for donors. (Anderlini P, Körbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, Howe C, Leitman S, Horowitz M, Gluckman E, Rowley S, Przepiorka D, Champlin R) Blood 1997 Aug 01;90(3):903-8 PMID: 9242518 SCOPUS ID: 2-s2.0-0031203157 08/01/1997 194 CitationsBone marrow transplantation for severe aplastic anemia: has outcome improved? (Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, Speck B, Tichelli A, Zhang MJ, Horowitz MM, Bortin MM) Blood 1997 Jul 15;90(2):858-64 PMID: 9226187 SCOPUS ID: 2-s2.0-0030877514 07/15/1997 129 CitationsEffect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. (Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA) Bone Marrow Transplant 1997 Jun;19(11):1069-77 PMID: 9193748 SCOPUS ID: 2-s2.0-0030982179 06/01/1997 51 CitationsIBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. (Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM) Br J Haematol 1997 Jun;97(4):855-64 PMID: 9217189 SCOPUS ID: 2-s2.0-8544247155 06/01/1997 561 CitationsHigh-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. (Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM) J Clin Oncol 1997 May;15(5):1870-9 PMID: 9164197 SCOPUS ID: 2-s2.0-0030979431 05/01/1997 309 CitationsResults of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. (Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM) J Clin Oncol 1997 May;15(5):1767-77 PMID: 9164184 SCOPUS ID: 2-s2.0-0030965047 05/01/1997 419 CitationsSolid cancers after bone marrow transplantation. (Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr) N Engl J Med 1997 Mar 27;336(13):897-904 PMID: 9070469 SCOPUS ID: 2-s2.0-9844227997 03/27/1997 818 CitationsResults of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. (Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP, Kolb HJ, Stevens DA, Horowitz MM, Gale RP) Ann Intern Med 1997 Jan 15;126(2):116-22 PMID: 9005745 SCOPUS ID: 2-s2.0-0031034490 01/15/1997 65 CitationsLong-term outcome of allogeneic bone marrow transplantation (BMT) for wiskott aldr1ch syndrome (WAS) (Filipovich AH, Sobocinski K, Pelz C, Ireland M, Kollman C, Horowitz MM) Experimental Hematology 1996;24(9):1143 SCOPUS ID: 2-s2.0-33748602371 12/01/1996 Effect of prior interferon therapy on outcome of hla-identical sibling bone marrow transplants for chronic myelogenous leukemia (CML) in first chronic phase (Horowitz MM, Giralt R Szvdlo S, Goldman J, Veum-Slone J) Experimental Hematology 1996;24(9):1143 SCOPUS ID: 2-s2.0-0042551936 12/01/1996 5 CitationsHLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. (Gale RP, Büchner T, Zhang MJ, Heinecke A, Champlin RE, Dicke KA, Gluckman E, Good RA, Gratwohl A, Herzig RH, Keating A, Klein JP, Marmont AM, Prentice HG, Rowlings PA, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Leukemia 1996 Nov;10(11):1687-91 PMID: 8892667 SCOPUS ID: 2-s2.0-10344225040 11/01/1996 37 CitationsAllogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. (Horowitz MM, Rowlings PA, Passweg JR) Bone Marrow Transplant 1996 May;17 Suppl 3:S5-6 PMID: 8769690 SCOPUS ID: 2-s2.0-0029952614 05/01/1996 110 CitationsCurrent controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia. (Heimpel H, Allan NC, Baccarani M, Guilhot F, Hehlmann R, Horowitz M, Kluin-Nelemans J, Schaefer U, Storb R, Thaler J) Bone Marrow Transplant 1996 May;17 Suppl 3:S39 PMID: 8769699 SCOPUS ID: 2-s2.0-0029999314 05/01/1996 1 CitationBone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. (Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL Jr, Pavlovsky S, Peterson FB, Rowlings PA, Russell JA, Silver SM, Vose JM, Wiernik PH, Bortin MM, Horowitz MM) J Clin Oncol 1996 Feb;14(2):572-8 PMID: 8636773 SCOPUS ID: 2-s2.0-9044237273 02/01/1996 186 CitationsChemotherapy versus transplants for acute myelogenous leukemia in second remission. (Gale RP, Horowitz MM, Rees JK, Gray RG, Oken MM, Estey EH, Kim KM, Zhang MJ, Ash RC, Atkinson K, Champlin RE, Dicke KA, Gajewski JL, Goldman JM, Helbig W, Henslee-Downey PS, Hinterberger W, Jacobsen N, Keating A, Klein JP, Marmont AM, Prentice HG, Reiffers J, Rimm AA, Bortin MM) Leukemia 1996 Jan;10(1):13-9 PMID: 8558917 SCOPUS ID: 2-s2.0-9044235781 01/01/1996 65 CitationsRisk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. (Rozman C, Carreras E, Qian C, Gale RP, Bortin MM, Rowlings PA, Ash RC, Champlin RE, Henslee-Downey PJ, Herzig RH, Hinterberger W, Klein JP, Prentice HG, Reiffers J, Zwaan FE, Horowitz MM) Bone Marrow Transplant 1996 Jan;17(1):75-80 PMID: 8673059 SCOPUS ID: 2-s2.0-13344250481 01/01/1996 93 CitationsUse of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. (Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR) Blood 1995 Nov 15;86(10):3987-96 PMID: 7579370 SCOPUS ID: 2-s2.0-0028856613 11/15/1995 59 CitationsBone marrow transplantation for Fanconi anemia. (Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W, Good RA, Gordon-Smith EC, Harris RE, Klein JP, Ortega JJ, Pasquini R, Ramsay NK, Speck B, Vowels MR, Zhang MJ, Gale RP) Blood 1995 Oct 01;86(7):2856-62 PMID: 7670120 SCOPUS ID: 2-s2.0-0029157355 10/01/1995 223 CitationsLong-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. (Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Löffler H, Sobocinski KA, Thiel E, Weisdorf DJ) Ann Intern Med 1995 Sep 15;123(6):428-31 PMID: 7639442 SCOPUS ID: 2-s2.0-0029161637 09/15/1995 91 CitationsTherapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. (Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C) Bone Marrow Transplant 1995 Aug;16(2):271-5 PMID: 7581147 SCOPUS ID: 2-s2.0-0029150064 08/01/1995 99 CitationsImpact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. (Gale RP, Horowitz MM, Weiner RS, Ash RC, Atkinson K, Babu R, Dicke KA, Klein JP, Lowenberg B, Reiffers J) Bone Marrow Transplant 1995 Aug;16(2):203-8 PMID: 7581137 SCOPUS ID: 2-s2.0-0029118359 08/01/1995 99 CitationsTransplants for multiple myeloma (Barlogie B, Anderson K, Berenson J, Crowley J, Cunningham D, Gertz M, Henon P, Horowitz M, Jagannath S, Powles R, Reece D, Reiffers J, Salmon S, Tricot G, Vesole D) Bone Marrow Transplantation 1995;15(SUPPL. 1) SCOPUS ID: 2-s2.0-20244382091 07/26/1995 13 CitationsAllogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells. (Barquinero J, Witherspoon R, Sanders J, Horowitz MM, Montuoro A, Patton DF, Bacigalupo A, Abecasis MM, Miale T, Rozman C) Br J Haematol 1995 Jul;90(3):595-601 PMID: 7646999 SCOPUS ID: 2-s2.0-0029018129 07/01/1995 5 CitationsBone-marrow transplantation for leukaemia. (Gale RP, Goldman JM, Horowitz MM, Silberman G, Crosse MG, Peterson EA, Weston RC) Lancet 1995 May 13;345(8959):1235 PMID: 7739318 05/13/1995 Bone-marrow transplantation for leukaemia. (Shaw PJ) Lancet 1995 May 13;345(8959):1235-6 PMID: 7605459 SCOPUS ID: 2-s2.0-0029643009 05/13/1995 1 CitationUnrelated bone marrow donor transplants for children with leukemia or myelodysplasia. (Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F) Blood 1995 May 01;85(9):2354-63 PMID: 7727769 SCOPUS ID: 2-s2.0-0028921178 05/01/1995 132 CitationsUse of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients. (Baxter-Lowe LA, Keever C, Dinauer D, Daniels T, Johnson K, Camitta B, Drobyski W, Garbrecht F, Horowitz M, Pietryga D) Transplant Proc 1995 Feb;27(1):1377-8 PMID: 7878917 SCOPUS ID: 2-s2.0-0028804487 02/01/1995 6 CitationsBone marrow transplantation for Diamond-Blackfan anemia. (Mugishima H, Gale RP, Rowlings PA, Horowitz MM, Marmont AM, McCann SR, Sobocinski KA, Bortin MM) Bone Marrow Transplant 1995 Jan;15(1):55-8 PMID: 7742755 SCOPUS ID: 2-s2.0-0028924937 01/01/1995 42 CitationsReport from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. (Passweg JR, Rowlings PA, Armitage JO, Gale RP, Pelz CJ, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM) Clin Transpl 1995:117-27 PMID: 8794259 SCOPUS ID: 2-s2.0-0029445232 01/01/1995 28 CitationsHLA-identical sibling bone marrow transplants for acute lymphoblastic leukemia (Gale RP, Butturini A, Horowitz MM) Bone Marrow Transplantation 1995;15(SUPPL. 1) SCOPUS ID: 2-s2.0-0029043242 01/01/1995 1 CitationBone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. (Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA) N Engl J Med 1994 Nov 10;331(19):1253-8 PMID: 7935682 SCOPUS ID: 2-s2.0-0028109796 11/10/1994 211 CitationsAvailability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. (Silberman G, Crosse MG, Peterson EA, Weston RC, Horowitz MM, Appelbaum FR, Cheson BD) N Engl J Med 1994 Oct 20;331(16):1063-7 PMID: 8090167 SCOPUS ID: 2-s2.0-0028116353 10/20/1994 54 CitationsComparison of chemotherapy and bone marrow transplants using two independent clinical databases. (Messerer D, Neiss A, Horowitz MM, Hoelzer D, Gale RP) J Clin Epidemiol 1994 Oct;47(10):1119-26 PMID: 7722545 SCOPUS ID: 2-s2.0-0028034069 10/01/1994 3 CitationsStat bite: Autologous bone marrow transplates for cancer, 1989–1993 (Horowitz MM) Journal of the National Cancer Institute 20 July 1994;86(14):1045 SCOPUS ID: 2-s2.0-13044299882 07/20/1994 1 CitationBone marrow transplantation for chronic myelogenous leukemia. (Litzow MR, Tefferi A) Blood 1994 May 01;83(9):2752-3 PMID: 8167356 SCOPUS ID: 2-s2.0-0028215563 05/01/1994 2 CitationsIdentical-twin bone marrow transplants for leukemia. (Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringdén O, Stone JA, Bortin MM) Ann Intern Med 1994 Apr 15;120(8):646-52 PMID: 8135448 SCOPUS ID: 2-s2.0-0028204442 04/15/1994 250 CitationsEffect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. (Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F) Blood 1994 Apr 01;83(7):1980-7 PMID: 8142664 SCOPUS ID: 2-s2.0-0028179358 04/01/1994 124 CitationsIncreasing incidence of adenovirus disease in bone marrow transplant recipients. (Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, McAuliffe T, Camitta B, Horowitz MM, Bunin N) J Infect Dis 1994 Apr;169(4):775-81 PMID: 8133091 SCOPUS ID: 2-s2.0-0028256278 04/01/1994 314 CitationsReport from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. (Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM) Clin Transpl 1994:87-98 PMID: 7547596 SCOPUS ID: 2-s2.0-0028700481 01/01/1994 4 CitationsBone marrow transplantation in leukemia. (Rowlings PA, Gale RP, Horowitz MM, Bortin MM) J Hematother 1994;3(3):235-8 PMID: 7827872 SCOPUS ID: 2-s2.0-0028674198 01/01/1994 5 CitationsBone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (Sobocinski KA, Horowitz MM, Rowlings PA, Zhang MJ, Nugent ML, Passweg JR, Armitage JO, Gale RP, Bortin MM) J Hematother 1994;3(2):95-102 PMID: 7922018 SCOPUS ID: 2-s2.0-0027934748 01/01/1994 33 CitationsComponent processing and intraoperative autotransfusion during bone marrow harvest. (Cook-Craig A, Owen A, Reeder G, Drobyski W, Horowitz M, Brunner J, Flomenberg N, Keever C) Prog Clin Biol Res 1994;389:613-9 PMID: 7700927 SCOPUS ID: 2-s2.0-0028720394 01/01/1994 1 CitationCox regression in a markov renewal model: An application to the analysis of bone marrow transplant data (Dabrowska DM, Sun GW, Horowitz MM) Journal of the American Statistical Association September 1994;89(427):867-877 SCOPUS ID: 2-s2.0-21844487283 01/01/1994 52 CitationsIn Reply (Ringdén O, Horowitz MM, Bortin MM) JAMA: The Journal of the American Medical Association 1 December 1993;270(21):2560 SCOPUS ID: 2-s2.0-84942479120 12/01/1993 Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. (Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM) Blood 1993 Oct 15;82(8):2310-8 PMID: 8400284 SCOPUS ID: 2-s2.0-0027437385 10/15/1993 334 CitationsChoice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. (Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A) Blood 1993 Oct 01;82(7):2235-8 PMID: 8400272 SCOPUS ID: 2-s2.0-0027504040 10/01/1993 191 Citations1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Rowlings PA, Rimm AA, Sobocinski KA, Zhang MJ, Gale RP) Bone Marrow Transplant 1993 Aug;12(2):97-104 PMID: 8401371 SCOPUS ID: 2-s2.0-0027288422 08/01/1993 59 CitationsOutcome after allogeneic bone marrow transplant for leukemia in older adults. (Ringdén O, Horowitz MM, Gale RP, Biggs JC, Gajewski J, Rimm AA, Speck B, Veum-Stone JA, de Witte T, Bortin MM) JAMA 1993 Jul 07;270(1):57-60 PMID: 8510297 SCOPUS ID: 2-s2.0-0027180906 07/07/1993 126 CitationsThe role of the International Bone Marrow Transplant Registry in assessing clinical efficacy. (Horowitz MM) Leukemia 1993 Jul;7(7):1106 PMID: 8321036 SCOPUS ID: 2-s2.0-0027636303 07/01/1993 Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. (Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, Flomenberg N, Carrigan DR) J Infect Dis 1993 Mar;167(3):735-9 PMID: 8382723 SCOPUS ID: 2-s2.0-0027458632 03/01/1993 225 CitationsMethotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? (Ringdén O, Horowitz MM, Sondel P, Gale RP, Biggs JC, Champlin RE, Deeg HJ, Dicke K, Masaoka T, Powles RL) Blood 1993 Feb 15;81(4):1094-101 PMID: 8427991 SCOPUS ID: 2-s2.0-0027525864 02/15/1993 169 CitationsResults of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. A report from the International Bone Marrow Transplant Registry. (Horowitz MM, Bortin MM) Am J Pediatr Hematol Oncol 1993 Feb;15(1):56-64 PMID: 8383476 SCOPUS ID: 2-s2.0-0027409794 02/01/1993 19 CitationsAnti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors. (Krance R, Heslop HE, Mahmoud H, Ribeiro R, Douglass E, Hurwitz C, Santana V, Kun L, Horowitz MM, Brenner MK) Bone Marrow Transplant 1993 Jan;11(1):33-6 PMID: 8431709 SCOPUS ID: 2-s2.0-0027462743 01/01/1993 9 CitationsReport from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (Rowlings PA, Horowitz MM, Armitage JO, Gale RP, Sobocinski KA, Zhang MJ, Bortin MM) Clin Transpl 1993:101-8 PMID: 7918143 SCOPUS ID: 2-s2.0-0027792006 01/01/1993 6 CitationsPredicting results of alternative donor transplants for thalassemia using a chronic myelogenous leukemia model. (Gale RP, Horowitz MM) Bone Marrow Transplant 1993;12 Suppl 1:82-3 PMID: 8374572 SCOPUS ID: 2-s2.0-0027237777 01/01/1993 1 CitationAlternative donor transplants for leukemia. Scientific Advisory Committee of the International Bone Marrow Transplant Registry. (Gale RP, Horowitz MM) Bone Marrow Transplant 1993;11 Suppl 1:66-7 PMID: 8448552 SCOPUS ID: 2-s2.0-0027523646 01/01/1993 3 CitationsTransplantation for acute leukemia in small versus large centers. (Gustafson JT, Cass H) Blood 1993 Jan 01;81(1):265 PMID: 8417796 SCOPUS ID: 2-s2.0-0027492743 01/01/1993 1 CitationBone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. (Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringdén O) Blood 1992 Aug 15;80(4):1090-3 PMID: 1498326 SCOPUS ID: 2-s2.0-0026754295 08/15/1992 187 CitationsChanging trends in allogeneic bone marrow transplantation for leukemia in the 1980s. (Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA, Gluckman E, Kolb HJ, Marmont AM, Mrsic M) JAMA 1992 Aug 05;268(5):607-12 PMID: 1321298 SCOPUS ID: 2-s2.0-0026638812 08/05/1992 74 CitationsWhat determines who develops graft-versus-host disease: the graft or the host (or both)? (Gale RP, Horowitz MM, Butturini A, Barrett AJ, Kolb HJ) Bone Marrow Transplant 1992 Aug;10(2):99-102 PMID: 1525613 SCOPUS ID: 2-s2.0-0026699425 08/01/1992 7 CitationsProgress report from the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Rimm AA) Bone Marrow Transplant 1992 Aug;10(2):113-22 PMID: 1525599 SCOPUS ID: 2-s2.0-0026768955 08/01/1992 22 CitationsBone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. (Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE) Blood 1992 Jun 01;79(11):3067-70 PMID: 1586748 SCOPUS ID: 2-s2.0-0026636931 06/01/1992 179 CitationsShould HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? (Horowitz MM, Przepiorka D, Champlin RE, Gale RP, Gratwohl A, Herzig RH, Prentice HG, Rimm AA, Ringdén O, Bortin MM) Blood 1992 May 15;79(10):2771-4 PMID: 1586723 SCOPUS ID: 2-s2.0-0026652724 05/15/1992 54 CitationsWhat is the best strategy for autotransplants in cancer? (Gale RP, Butturini A, Horowitz M) Bone Marrow Transplant 1992 May;9(5):303 PMID: 1617312 SCOPUS ID: 2-s2.0-0026594133 05/01/1992 3 CitationsSecond HLA-identical sibling transplants for leukemia recurrence. (Mrsíc M, Horowitz MM, Atkinson K, Biggs JC, Champlin RE, Ehninger G, Gajewski JL, Gale RP, Herzig RH, Prentice HG) Bone Marrow Transplant 1992 Apr;9(4):269-75 PMID: 1600415 SCOPUS ID: 2-s2.0-0026524521 04/01/1992 164 CitationsIncreasing utilization of allogeneic bone marrow transplantation. Results of the 1988-1990 survey. (Bortin MM, Horowitz MM, Rimm AA) Ann Intern Med 1992 Mar 15;116(6):505-12 PMID: 1739242 SCOPUS ID: 2-s2.0-0026559448 03/15/1992 123 CitationsProgress in allogeneic bone marrow transplantation for acute lymphoblastic leukemia in the 1980's: a report from the IBMTR. The International Bone Marrow Transplant Registry. (Bortin MM, Barrett AJ, Horowitz MM, Gale RP, Sobocinski KA, Rimm AA) Leukemia 1992;6 Suppl 2:196-7 PMID: 1578932 SCOPUS ID: 2-s2.0-0026681337 01/01/1992 12 CitationsTherapy decisions in leukemia. (Atkinson KA, Horowitz MM, Sobocinski KA, Rimm AA, Bortin MM, Gale RP) Bone Marrow Transplant 1992 Jan;9(1):5-10 PMID: 1543950 SCOPUS ID: 2-s2.0-0026585639 01/01/1992 8 CitationsBone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. (Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM) Blood 1992 Jan 01;79(1):269-75 PMID: 1728315 SCOPUS ID: 2-s2.0-0026516811 01/01/1992 151 CitationsReport from the International Bone Marrow Transplant Registry. (Rowlings PA, Horowitz MM, Rimm AA, Sobocinski KA, Zhang MJ, Bortin MM) Clin Transpl 1992:83-90 PMID: 1306725 SCOPUS ID: 2-s2.0-0027018227 01/01/1992 2 CitationsTransplants in ALL. (Barrett AJ, Horowitz MM) Bone Marrow Transplant 1992;10 Suppl 1:30-6 PMID: 1521088 SCOPUS ID: 2-s2.0-0026778053 01/01/1992 3 CitationsCancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. (Kolb HJ, Guenther W, Duell T, Socie G, Schaeffer E, Holler E, Schumm M, Horowitz MM, Gale RP, Fliedner TM) Bone Marrow Transplant 1992;10 Suppl 1:135-8 PMID: 1521085 SCOPUS ID: 2-s2.0-0026694859 01/01/1992 24 CitationsCurrent status of allogeneic bone marrow transplantation. (Sobocinski KA, Horowitz MM, Rimm AA, Bortin MM) Biomed Pharmacother 1992;46(2-3):57-69 PMID: 1421039 SCOPUS ID: 2-s2.0-0026742006 01/01/1992 7 CitationsT-cell depletion of HLA-identical transplants in leukemia. (Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA) Blood 1991 Oct 15;78(8):2120-30 PMID: 1912589 SCOPUS ID: 2-s2.0-0026049124 10/15/1991 734 CitationsChemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. (Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G) Ann Intern Med 1991 Jul 01;115(1):13-8 PMID: 2048858 SCOPUS ID: 2-s2.0-0025915728 07/01/1991 143 CitationsDoes more intensive therapy increase cures in acute leukemia? (Gale RP, Butturini A, Horowitz MM) Semin Hematol 1991 Jul;28(3 Suppl 4):93-4 PMID: 1780762 SCOPUS ID: 2-s2.0-0025860652 07/01/1991 2 CitationsEvaluating new therapy for acute myeloid leukemia. (Keating A, Horowitz MM) Semin Hematol 1991 Jul;28(3 Suppl 4):70-1 PMID: 1780755 SCOPUS ID: 2-s2.0-0025859852 07/01/1991 Possible prevention of Pneumocystis carinii pneumonia by pentamidine aerosol after bone marrow transplantation. (Mahon FX, Sadoun A, Benz-Lemoine E, Roblot-Casenave F, Guilhot F, Tanzer J) Bone Marrow Transplant 1991 Jul;8(1):64-5 PMID: 1912958 SCOPUS ID: 2-s2.0-0025740046 07/01/1991 9 CitationsBone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. (Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC, Henslee PJ, Kolb HJ, Lowenberg B, Masaoka T) Bone Marrow Transplant 1991 Jun;7(6):443-52 PMID: 1873591 SCOPUS ID: 2-s2.0-0025817169 06/01/1991 191 CitationsAutotransplants in acute leukaemia. (Gale RP, Horowitz MM, Butturini A) Br J Haematol 1991 May;78(1):135-7 PMID: 2043473 SCOPUS ID: 2-s2.0-0025765829 05/01/1991 13 CitationsDuration of response to intramuscular versus low dose intradermal hepatitis B booster immunization. (McKinney WP, Russler SK, Horowitz MM, Battiola RJ, Lee MB) Infect Control Hosp Epidemiol 1991 Apr;12(4):226-30 PMID: 1829469 SCOPUS ID: 2-s2.0-0026146918 04/01/1991 8 CitationsProgress in bone marrow transplantation for leukemia: a preliminary report from the Advisory Committee of the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Mrsic M, Rimm AA, Sobocinski KA) Transplant Proc 1991 Feb;23(1 Pt 1):61-2 PMID: 1990623 SCOPUS ID: 2-s2.0-0025974321 02/01/1991 15 CitationsUse of a clinical data registry to evaluate medical technologies. Experience from the International Bone Marrow Transplant Registry. (Rimm AA, Barr JT, Horowitz MM, Bortin MM) Int J Technol Assess Health Care 1991;7(2):182-93 PMID: 1864702 SCOPUS ID: 2-s2.0-0025862291 01/01/1991 9 CitationsHow best to analyse new strategies in bone marrow transplantation. (Gale RP, Horowitz MM) Bone Marrow Transplant 1990 Dec;6(6):357-9 PMID: 2097005 SCOPUS ID: 2-s2.0-0025611149 12/01/1990 8 CitationsGraft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry. (Gale RP, Horowitz MM) Bone Marrow Transplant 1990 Jul;6 Suppl 1:94-7 PMID: 2390646 SCOPUS ID: 2-s2.0-0025164598 07/01/1990 28 CitationsRisk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. (Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringdén O) Blood 1990 Jun 15;75(12):2459-64 PMID: 2350582 SCOPUS ID: 2-s2.0-0025292356 06/15/1990 323 CitationsGraft-versus-leukemia reactions after bone marrow transplantation. (Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B) Blood 1990 Feb 01;75(3):555-62 PMID: 2297567 SCOPUS ID: 2-s2.0-0025100777 02/01/1990 2511 CitationsCurrent status of allogeneic bone marrow transplantation. (Horowitz MM, Bortin MM) Clin Transpl 1990:41-52 PMID: 2103163 SCOPUS ID: 2-s2.0-0025620167 01/01/1990 14 CitationsIBMTR analysis of bone marrow transplants in acute leukaemia. Advisory Committee of the International Bone Marrow Transplant Registry (IBMTR). (Gale RP, Horowitz MM, Bortin MM) Bone Marrow Transplant 1989 Dec;4 Suppl 3:83-4 PMID: 2697411 SCOPUS ID: 2-s2.0-0024847173 12/01/1989 9 CitationsMarrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. (Barrett AJ, Horowitz MM, Gale RP, Biggs JC, Camitta BM, Dicke KA, Gluckman E, Good RA, Herzig RH, Lee MB) Blood 1989 Aug 01;74(2):862-71 PMID: 2665858 SCOPUS ID: 2-s2.0-0024337547 08/01/1989 218 CitationsTemporal relationships between the major complications of bone marrow transplantation for leukemia. (Bortin MM, Ringdén O, Horowitz MM, Rozman C, Weiner RS, Rimm AA) Bone Marrow Transplant 1989 Jul;4(4):339-44 PMID: 2673453 SCOPUS ID: 2-s2.0-0024422933 07/01/1989 37 CitationsProposals for standardized reporting of results of bone marrow transplantation for leukaemia. (Clift R, Goldman J, Gratwohl A, Horowitz M) Bone Marrow Transplant 1989 Jul;4(4):445-8 PMID: 2673466 SCOPUS ID: 2-s2.0-0024694111 07/01/1989 75 CitationsTransplant or chemotherapy in acute myelogenous leukaemia. International Bone Marrow Transplant Registry. Lancet 1989 May 20;1(8647):1119-22 PMID: 2566059 SCOPUS ID: 2-s2.0-0024511774 05/20/1989 60 CitationsConsensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. (Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM) Bone Marrow Transplant 1989 May;4(3):247-54 PMID: 2659110 SCOPUS ID: 2-s2.0-0024412271 05/01/1989 168 CitationsReport from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989 May;4(3):221-8 PMID: 2659107 SCOPUS ID: 2-s2.0-0024385451 05/01/1989 69 CitationsRisk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anaemia. (Weiner RS, Horowitz MM, Gale RP, Dicke KA, van Bekkum DW, Masaoka T, Ramsay NK, Rimm AA, Rozman C, Bortin MM) Br J Haematol 1989 Apr;71(4):535-43 PMID: 2653409 SCOPUS ID: 2-s2.0-0024477284 04/01/1989 60 CitationsEffect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia. International Bone Marrow Transplant Registry. Lancet 1989 Mar 11;1(8637):535-7 PMID: 2564066 SCOPUS ID: 2-s2.0-84921620400 03/11/1989 24 CitationsGraft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. (Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C) Blood 1989 Feb;73(2):606-13 PMID: 2644980 SCOPUS ID: 2-s2.0-0024592842 02/01/1989 286 CitationsSusceptibility of hospital-based health care personnel to varicella-zoster virus infections. (McKinney WP, Horowitz MM, Battiola RJ) Am J Infect Control 1989 Feb;17(1):26-30 PMID: 2538095 SCOPUS ID: 2-s2.0-0024576852 02/01/1989 42 CitationsGraft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry. (Ringdén O, Horowitz MM) Transplant Proc 1989 Feb;21(1 Pt 3):2989-92 PMID: 2650409 SCOPUS ID: 2-s2.0-0024596263 02/01/1989 70 CitationsFactors influencing the risk of acute and chronic graft-versus-host disease in humans: a preliminary report from the IBMTR. (Bortin MM, Atkinson K, van Bekkum DW, Biggs JC, Dicke KA, Gale RP, Gluckman E, Good RA, Hoffmann RG, Horowitz MM) Bone Marrow Transplant 1989 Jan;4 Suppl 1:222-4 PMID: 2653507 SCOPUS ID: 2-s2.0-0024584162 01/01/1989 3 CitationsBone marrow transplantation for acute lymphoblastic leukaemia in first and second remission. (Barrett AJ, Horowitz MM, McCarthy DM, Kanfer E, Bortin MM) Bone Marrow Transplant 1989 Jan;4 Suppl 1:247-9 PMID: 2653514 SCOPUS ID: 2-s2.0-0024517824 01/01/1989 2 CitationsCurrent status of bone marrow transplantation. (Bortin MM, Horowitz MM) Clin Transpl 1989:93-104 PMID: 2487630 SCOPUS ID: 2-s2.0-0024919473 01/01/1989 7 CitationsBone marrow transplantation for thalassaemia--a preliminary report from the International Bone Marrow Transplant Registry. (Barrett AJ, Lucarelli G, Gale RP, Sobocinski A, Horowitz M, Bortin MM) Prog Clin Biol Res 1989;309:173-85 PMID: 2675084 SCOPUS ID: 2-s2.0-0024387521 01/01/1989 10 CitationsBone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. (Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB) Ann Intern Med 1988 Jun;108(6):806-14 PMID: 3285744 SCOPUS ID: 2-s2.0-0023690307 06/01/1988 826 CitationsDuration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. (Horowitz MM, Ershler WB, McKinney WP, Battiola RJ) Ann Intern Med 1988 Feb;108(2):185-9 PMID: 2963570 SCOPUS ID: 2-s2.0-0023875532 02/01/1988 99 CitationsCurrent status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Gale RP) Nat Immun Cell Growth Regul 1988;7(5-6):334-50 PMID: 3065641 SCOPUS ID: 2-s2.0-0024204303 01/01/1988 24 CitationsThe clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers. (Atkinson K, Horowitz MM, Biggs JC, Gale RP, Rimm AA, Bortin MM) Bone Marrow Transplant 1988 Jan;3(1):5-10 PMID: 3048470 SCOPUS ID: 2-s2.0-0023830925 01/01/1988 38 CitationsAttitudes of faculty members, residents, students, and community physicians toward health promotion. (Horowitz MM, Byrd JC, Gruchow HW) J Med Educ 1987 Nov;62(11):931-4 PMID: 3681923 SCOPUS ID: 2-s2.0-84947648512 11/01/1987 13 CitationsBone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. (Herzig RH, Bortin MM, Barrett AJ, Blume KG, Gluckman E, Horowitz MM, Jacobsen SJ, Marmont A, Masaoka T, Prentice HG) Lancet 1987 Apr 04;1(8536):786-9 PMID: 2882192 SCOPUS ID: 2-s2.0-0023119122 04/04/1987 47 Citations[Kinin-inactivating enzymes from plants. 1. Partial purification of bradykinin-inactivating enzyme from potatoes]. (Hojima Y, Tanaka M, Moriya H, Moriwaki C) Arerugi 1971 Oct;20(10):755-62 PMID: 5145732 SCOPUS ID: 2-s2.0-0015136673 10/01/1971 13 Citations
© 2024 Clinical & Translational Science Institute